rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCTGTCAGGGGATGGAAACACCATATATTTTGGAGAG	CASTLSGDGNTIYF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	2	3	6	1	23	33	45	39	46			01,02										Vb 1	CASTLSGDGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCATCTACAGGGGATGGGGAGACCCAGTACTTCGGGCCA	CASSSSTGDGETQYF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	5	6	5	23	35	48	41	53			01,02										Vb 1	CASSSSTGDGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGGACGGGACTAGCGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSVDGTSGGQETQYF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	5	2	4	4	23	37	52	41	56			01,02			01,02							Vb 1	CASSVDGTSGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTGACTAGCGGCCCTCCGGGGGATACGCAGTATTTTGGCCCA	CASSLTSGPPGDTQYF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	5	6	2	10	23	35	46	37	56			01,02			01,02							Vb 1	CASSLTSGPPGDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCTGTTGCCGGGCACACTATGGCTACACCTTCGGTTCG	CACCRAHYGYTF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	36	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	10	8	0	3	7	2	23	29	40	36	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CACCRAHYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCCCCCGGGACAGACCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	61	4.7386369815659253E-4		43	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	5	2	5	4	23	32	44	37	48			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATCCGGGACAGGAGGAAACACCATATATTTTGGAGAG	CASSVSGTGGNTIYF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	4	4	3	1	23	38	49	41	50			01,02										Vb 1	CASSVSGTGGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACAGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSAQGGTGELFF	In	VDJ	1	98	7.612892199892798E-4	0.0010104655359076146	42	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	3	3	3	4	1	3	23	36	43	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAQGGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGGGAACGGGGGATTCTACGAGCAGTACTTCGGGCCG	CASSEGNGGFYEQYF	In	VDJ	1	115	8.933495948853793E-4	0.0011857503737691395	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	3	9	3	23	34	49	43	52			01,02										Vb 1	CASSEGNGGFYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTATAGCGGGATATCGGTACAATGAGCAGTTCTTCGGGCCA	CASSVGIAGYRYNEQFF	In	VDJ	1	123	9.554956536600145E-4	0.0012682373562922101	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	3	4	3	6	23	39	50	42	56			01,02										Vb 1	CASSVGIAGYRYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTACGGAGGGGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	124	9.632639110068439E-4		58	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	4	0	9	0	23	39	-1	48	60			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAACAGATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	132	0.001025409969781479		41	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	5	4	1	2	23	39	44	40	46			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAACACAGCCACAGATACGCAGTATTTTGGCCCA	CASSVNTATDTQYF	In	VDJ	1	141	0.0010953242859029434	0.001453833066969119	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	5	2	3	1	23	38	45	41	46			01,02										Vb 1	CASSVNTATDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTTTTAGCGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPFSGFTGELFF	In	VDJ	1	143	0.0011108608005966022	0.0014744548125998865	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	4	4	5	2	23	35	47	40	49			01,02			01,02							Vb 1	CASSPFSGFTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCARCCCAAACACAGATACGCAGTATTTTGGCCCA	CASXPNTDTQYF	In	VDJ	1	158	0.0012273846607990429	0.0016291179048306438	36	TCRBV09	TCRBV09-01		unresolved			TCRBJ02	TCRBJ02-03	01	4	4	6	2	1	2	23	35	38	36	40			01,02	TCRBD01,TCRBD02									Vb 1	CASXPNTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	unresolved	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTCCGGCTAGCGGATATCAATGAGCAGTTCTTCGGGCCA	CASSVVRLADINEQFF	In	VDJ	1	184	0.001429359351816607	0.0018972005980306232	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	5	6	5	4	23	39	51	44	55			01,02			01,02							Vb 1	CASSVVRLADINEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTAAGGATCTACGAGCAGTACTTCGGGCCG	CASSLRIYEQYF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	36	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	5	1	8	3	4	1	29	41	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSLRIYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGGCAGCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSRAALNTEAFF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	0	0	5	29	-1	46	42	51													Vb 16	CASSRAALNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCAGGGACTTTAACTATGGCTACACCTTCGGTTCG	CASSRDFNYGYTF	In	VDJ	1	71	5.515462716248864E-4	7.320719698922514E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	1	1	1	29	41	48	42	49						01,02							Vb 16	CASSRDFNYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTACATGACCGGGGTATACAATGGGGTGAGCAGTTCTTCGGGCCA	CASSLHDRGIQWGEQFF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	3	9	8	12	29	42	55	50	67													Vb 16	CASSLHDRGIQWGEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAAGGGGCCGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	94	7.302161906019623E-4		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	0	2	3	29	42	49	44	52													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCAACTAGCGGGAAACGTCGGCAATGAGCAGTTCTTCGGGCCA	CASSQLAGNVGNEQFF	In	VDJ	1	106	8.234352787639149E-4	0.0010929525184306852	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	6	0	8	29	-1	53	44	61													Vb 16	CASSQLAGNVGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACAGGGACTACACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHRDYTNTGELFF	In	VDJ	1	113	8.778130801917206E-4	0.001165128628138372	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	9	0	2	2	29	43	52	45	54						01,02							Vb 16	CASSHRDYTNTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGACTAGCGGGAGGTATTAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	122	9.477273963131851E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	1	7	1	6	28	45	60	46	66													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGACAGACCCGCGGGGAGCAGTACTTCGGGCCG	CASSRQTRGEQYF	In	VDJ	1	140	0.001087556028556114	0.001443522194153735	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	4	2	5	7	0	9	29	-1	47	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRQTRGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATGTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	214	0.0016624070722214886		35	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	4	10	3	3	0	29	43	-1	46	48						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGTGGGGACAGGGATCGCTGCAGACCCAGTACTTCGGGCCA	CASSQWGQGSLQTQYF	In	VDJ	1	219	0.0017012483589556354	0.002258081146569057	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	6	3	8	29	43	55	46	63													Vb 16	CASSQWGQGSLQTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGCGGGACAGGGCCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	246	0.001910991307320029		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	3	6	4	1	29	45	58	49	59													Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGATCGGGGAGACCCAGTACTTCGGGCCA	CASSQGIGETQYF	In	VDJ	2	312	0.0024236962922107685	0.0032169923183997524	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	8	4	5	4	0	29	45	-1	49	53						01,02							Vb 16	CASSQGIGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCTACAGGGTATCTACAATGAGCAGTTCTTCGGGCCA	CASSLQGIYNEQFF	In	VDJ	8	1227	0.009531651764559656	0.01265144094447595	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	3	3	3	29	40	49	43	52													Vb 16	CASSLQGIYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGAGTTTATTTCTGTGCCAGCAGCCGCTAACGGGACAGACTAGACTAGCGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSR*RDRLD*RNYNEQFF	Stop	VDJ	22	3624	0.028152164624909694		60	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	5	3	17	2	12	25	51	42	53						01,02							Vb 16	CASSR*RDRLD*RNYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGTAGCGGGAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVAGGNTGELFF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	1	1	4	0	24	36	-1	40	50														CASSLVAGGNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGGGGGACCGATAGCTCTGGAAACACCATATATTTTGGAGAG	CARGTDSSGNTIYF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	10	0	7	0	2	6	24	31	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARGTDSSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCTAACCTAGCGGGAGGGGCAGAGACCCAGTACTTCGGGCCA	CASSANLAGGAETQYF	In	VDJ	1	112	8.700448228448912E-4	0.001154817755322988	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	0	4	6	2	24	36	54	42	56														CASSANLAGGAETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTAAAGCCGGAGAAAAACTGTTTTTTGGCAGT	CASSKAGEKLFF	In	VDJ	1	114	8.855813375385499E-4	0.0011754395009537558	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	0	1	8	8	1	0	24	41	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSKAGEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTCGGGGGGGACCTACACTGAAGCTTTCTTTGGACAA	CASSSGGTYTEAFF	In	VDJ	1	47	3.6510809530098114E-4	4.8461102232303966E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	3	0	4	18	-1	39	31	43														CASSSGGTYTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCCGTAGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRRENTGELFF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-02	01	5	0	8	1	4	0	18	30	-1	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRRENTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGACGAGCGTAAGGCTATGAACACTGAAGCTTTCTTTGGACAA	CASSEDERKAMNTEAFF	In	VDJ	5	763	0.0059271803556308214	0.007867195958137856	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	6	0	3	8	23	39	46	42	54						01,02								CASSEDERKAMNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGATATGAAACATGGCTACACCTTCGGTTCG	CASSLDMKHGYTF	In	VDJ	1	66	5.127049848907395E-4	6.805176058153323E-4	39	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-02	01	1	2	8	6	4	3	22	38	44	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDMKHGYTF+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGAACCGGGACAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CAWTNRDRGTGELFF	In	VDJ	1	53	4.1171763938195746E-4	5.464762592153426E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	1	5	6	0	26	36	-1	42	53			unresolved										Vb 20	CAWTNRDRGTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAACACCCCCTCCATGACAGAATGGCTACACCTTCGGTTCG	CAWSATPPP*QNGYTF	Stop	VDJ	1	55	4.272541540756162E-4		48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	6	15	1	26	39	59	54	60													Vb 20	CAWSATPPP*QNGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCAGTCCCCGGCAGGGCCACAGATACGCAGTATTTTGGCCCA	CAWSPVPGRATDTQYF	In	VDJ	1	63	4.894002128502513E-4	6.495849873691808E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	2	12	1	26	37	54	49	55													Vb 20	CAWSPVPGRATDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGGACTTGGGCTTTCTTTGGACAA	CAWSPGTWAFF	In	VDJ	1	76	5.903875583590333E-4	7.836263339691705E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	10	11	3	3	26	38	47	41	50			unresolved			01,02							Vb 20	CAWSPGTWAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGACAGGGGGCAAGTGGAAACACCATATATTTTGGAGAG	CAWSRQGASGNTIYF	In	VDJ	1	82	6.369971024400096E-4	8.454915708614734E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	2	0	3	1	3	26	38	49	39	52													Vb 20	CAWSRQGASGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGGGACAGATACGCAGTATTTTGGCCCA	CAWSVRGTDTQYF	In	VDJ	1	82	6.369971024400096E-4	8.454915708614734E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	2	3	1	0	26	40	-1	41	47													Vb 20	CAWSVRGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCTAGGTCCTGGGACTAGCGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	101	7.84593992029768E-4		49	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	6	2	10	2	26	33	53	43	55						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGGCTCATCAATGAGCAGTTCTTCGGGCCA	CAWSVGLINEQFF	In	VDJ	1	112	8.700448228448912E-4	0.001154817755322988	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	6	1	4	26	40	45	41	49			unresolved										Vb 20	CAWSVGLINEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCGGGACCGCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWNRDRSSGANVLTF	In	VDJ	1	127	9.86568683047332E-4	0.0013094808475537455	48	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-06	01	4	0	7	0	3	5	26	36	44	39	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNRDRSSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02		TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGCACTAGCGGGTTTGAGCAGTTCTTCGGGCCA	CAWSGTSGFEQFF	In	VDJ	1	134	0.0010409464844751378	0.0013816569572614322	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	4	9	2	2	26	39	50	41	52						01,02							Vb 20	CAWSGTSGFEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGCAATACATGGAATCGTGGCTACACCTTCGGTTCG	CAWSGNTWNRGYTF	In	VDJ	1	136	0.0010564829991687964	0.0014022787028921998	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	1	1	8	7	9	4	26	39	51	48	55			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGNTWNRGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCAGGTCGGAACCCAACTGTTTTTTGGCAGT	CAWSGQVGTQLFF	In	VDJ	1	141	0.0010953242859029434	0.001453833066969119	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	4	12	2	9	26	39	45	41	54			unresolved										Vb 20	CAWSGQVGTQLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGACAGGGTTACTATGGCTACACCTTCGGTTCG	CAWSVQGQGYYGYTF	In	VDJ	1	150	0.0011652386020244078	0.0015466309223075734	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	3	3	2	26	40	52	43	54													Vb 20	CAWSVQGQGYYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGCAGGGGGATACACCGGGGAGCTGTTTTTTGGAGAA	CAWNAGGYTGELFF	In	VDJ	1	162	0.0012584576901863605	0.0016703613960921792	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	1	3	3	2	26	36	46	39	48													Vb 20	CAWNAGGYTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCCAGGGACCACCTATGGCTACACCTTCGGTTCG	CAWTPGTTYGYTF	In	VDJ	1	163	0.0012662259475331899	0.0016806722689075631	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	0	7	4	5	3	26	36	46	41	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTPGTTYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCCGGGACTAGTATCCGGGGAGCTGTTTTTTGGAGAA	CAWSGPGLVSGELFF	In	VDJ	1	188	0.0014604323812039246	0.0019384440892921586	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	0	8	6	4	3	26	39	51	43	54						01,02							Vb 20	CAWSGPGLVSGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGGGGCGACGAAAAACTGTTTTTTGGCAGT	CAWKGGDEKLFF	In	VDJ	1	203	0.0015769562414063654	0.002093107181522916	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	4	5	1	8	0	5	26	-1	42	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGGDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAACAGGGTTCCTATGGCTACACCTTCGGTTCG	CAWEQGSYGYTF	In	VDJ	1	223	0.001732321388342953	0.0022993246378305923	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	4	2	3	26	35	43	37	46			unresolved										Vb 20	CAWEQGSYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCGACAGGGGGCGGGTGAGCAGTTCTTCGGGCCA	CAWTRQGAGEQFF	In	VDJ	2	251	0.0019498325940541757	0.0025880290766613395	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	9	3	3	26	36	49	39	52			unresolved										Vb 20	CAWTRQGAGEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACGGGAGAGGGAATGAGCAGTTCTTCGGGCCA	CAWSYGRGNEQFF	In	VDJ	2	257	0.001996442138135152	0.002649894313553642	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	8	2	7	2	4	26	38	46	40	50													Vb 20	CAWSYGRGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAAGGAGGGCCGAACACTGAAGCTTTCTTTGGACAA	CAWREGGPNTEAFF	In	VDJ	2	287	0.0022294898585400336	0.002959220498015157	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	1	4	2	26	37	47	41	49													Vb 20	CAWREGGPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGACCTAAACTATGGCTACACCTTCGGTTCG	CAWSVDLNYGYTF	In	VDJ	2	319	0.002478074093638574	0.003289168428107439	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	0	2	7	2	1	3	26	40	44	41	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCCGACCTCTCTGGAAACACCATATATTTTGGAGAG	CAWSVPDLSGNTIYF	In	VDJ	2	347	0.002695585299349797	0.0035778728669381863	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-03	01	0	2	7	0	4	2	26	40	47	44	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPDLSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02		TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGGAGTAGCGGGAAGCTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	387	0.0030063155932229723		49	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	3	1	6	4	26	37	51	43	55			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGGGATCGGACTATGGCTACACCTTCGGTTCG	CAWMGSDYGYTF	In	VDJ	3	533	0.004140481165860062	0.005495695210599577	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	4	0	8	3	1	4	26	36	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWMGSDYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCAATCGGACTAGCGGGCATCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSSIGLAGISYNEQFF	In	VDJ	4	658	0.0051115133342137355	0.006784554312522555	54	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	4	0	6	3	26	38	55	44	58			unresolved			01,02							Vb 20	CAWSSIGLAGISYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGAAAAGTCGGAGTTAGGTCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	704	0.005468853172167888		52	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	5	0	8	0	0	17	26	-1	39	35	56			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACCCCGGGGACATCCTTAAAGCTTTCTTTGGACAA	CASSLDPGDILKAFF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	6	9	6	6	19	35	47	41	53													Vb 5.1	CASSLDPGDILKAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGGACAGGGGGTTTCAAGAGAAAAACTGTTTTTTGGCAGT	CASSLGGQGVSREKLFF	In	VDJ	1	82	6.369971024400096E-4	8.454915708614734E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	1	8	2	8	19	35	47	37	55													Vb 5.1	CASSLGGQGVSREKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCCTTTATCTTTGCGACAGCAGCTTGGATCGCGGGAGAGGGAATGAGCAGTTCTTCGGGCCA	CDSSLDRGRGNEQFF	In	VDJ	1	123	9.554956536600145E-4	0.0012682373562922101	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	2	7	3	4	19	35	45	38	49													Vb 5.1	CDSSLDRGRGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGTTGAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	388	0.0030140838505698015		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	3	0	6	19	-1	43	35	49													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGTGGCGGTGGGGTTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	108	8.389717934575736E-4		38	TCRBV17	TCRBV17-01	01				TCRBJ02	TCRBJ02-01	01	0	6	2	8	4	2	22	36	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ02-01	TCRBV17-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGGTAGGCTATTGGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	116	9.011178522322087E-4		46	TCRBV17	TCRBV17-01	01				TCRBJ01	TCRBJ01-02	01	3	0	8	4	10	5	22	33	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCGGGTGGAAACACCATATATTTTGGAGAG	CASSSPGGNTIYF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	4	3	3	0	25	38	-1	41	45						01,02							Vb 3	CASSSPGGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTGGTGAAGTGAAAAATTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	54	4.194858967287868E-4		49	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	8	0	10	0	2	14	25	34	38	36	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACGAGGATGCCTACGAGCAGTACTTCGGGCCG	CASNEDAYEQYF	In	VDJ	1	75	5.826193010122039E-4	7.733154611537867E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	11	1	2	2	3	25	35	41	37	44													Vb 3	CASNEDAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCACCAGACCTATCTAACACTGAAGCTTTCTTTGGACAA	CASTPPDLSNTEAFF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	2	7	2	8	6	25	35	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTPPDLSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACAGGGGTGGGAGCCCCAGCATTTTGGTGAT	CASSPQGWEPQHF	In	VDJ	1	91	7.069114185614741E-4	9.382894261999278E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	8	2	4	25	37	46	39	50													Vb 3	CASSPQGWEPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCGAGGCGGGTTCTCTGGAAACACCATATATTTTGGAGAG	CASRRGGFSGNTIYF	In	VDJ	1	97	7.535209626424504E-4	0.0010001546630922307	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	6	7	4	0	5	2	25	36	46	41	48						01,02							Vb 3	CASRRGGFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAAAGCGCCCACCCAGACCCAGTACTTCGGGCCA		Out	VDJ	1	98	7.612892199892798E-4		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	6	6	4	7	25	36	44	40	51						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGAGTGATTGGGGGGGAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	100	7.768257346829386E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	9	0	3	10	2	25	35	52	45	54													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGAGGGACAGGGGATGGGCAATCAGCCCCAGCATTTTGGTGAT	CASEGQGMGNQPQHF	In	VDJ	1	102	7.923622493765973E-4	0.0010517090271691498	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	2	2	2	4	25	34	46	36	50													Vb 3	CASEGQGMGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGATTGGACAGTCCAACAATGAGCAGTTCTTCGGGCCA	CASKIGQSNNEQFF	In	VDJ	1	104	8.078987640702561E-4	0.0010723307727999176	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	5	5	5	4	25	35	46	40	50													Vb 3	CASKIGQSNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAACCACAGAGAACACTGAAGCTTTCTTTGGACAA	CASSPTTENTEAFF	In	VDJ	1	113	8.778130801917206E-4	0.001165128628138372	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	6	1	25	37	47	43	48													Vb 3	CASSPTTENTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACTCCGGGCGGAAAACTGTTTTTTGGCAGT	CASRTPGGKLFF	In	VDJ	1	121	9.399591389663557E-4	0.0012476156106614425	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	8	0	10	6	2	25	36	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRTPGGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGTAGACTAGCGGGAGAGGGGGAGACCCAGTACTTCGGGCCA	CASSRRLAGEGETQYF	In	VDJ	1	122	9.477273963131851E-4	0.0012579264834768262	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	2	5	5	5	25	36	53	41	58													Vb 3	CASSRRLAGEGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCGGGGAAGAGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	126	9.788004257005026E-4		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	3	6	3	6	25	35	43	38	49													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAATGGGCAGGACACAGATACGCAGTATTTTGGCCCA	CASSLNGQDTDTQYF	In	VDJ	1	129	0.0010021051977409908	0.0013301025931845131	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	4	2	6	1	25	40	50	46	51													Vb 3	CASSLNGQDTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCACCGACAGGGATTAGGCTACACCTTCGGTTCG	CASHRQGLGYTF	In	VDJ	1	129	0.0010021051977409908	0.0013301025931845131	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	8	4	4	25	34	45	38	49													Vb 3	CASHRQGLGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGCGGGAGAGTACTACGAGCAGTACTTCGGGCCG	CASSPAGEYYEQYF	In	VDJ	1	143	0.0011108608005966022	0.0014744548125998865	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	6	2	3	3	4	25	36	47	39	51													Vb 3	CASSPAGEYYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGCAGGGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSFAGGGNEQFF	In	VDJ	1	158	0.0012273846607990429	0.0016291179048306438	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	3	4	1	6	2	3	25	39	48	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFAGGGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGAGGGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSLGGVSGNTIYF	In	VDJ	1	173	0.0013439085210014837	0.0017837809970614013	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	9	0	0	0	2	25	-1	46	39	48													Vb 3	CASSLGGVSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCCGGTGATTACTACGAGCAGTACTTCGGGCCG	CASSFPGDYYEQYF	In	VDJ	1	186	0.0014448958665102657	0.001917822343661391	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	5	3	3	6	25	39	45	42	51						01,02							Vb 3	CASSFPGDYYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGTGGGTCAGGTTCAGCCCCAGCATTTTGGTGAT	CASVGQVQPQHF	In	VDJ	1	204	0.0015847244987531946	0.0021034180543382996	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	4	6	6	1	25	34	44	40	45													Vb 3	CASVGQVQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGACTAGCGTGGATGAGCAGTTCTTCGGGCCA	CASSSPTSVDEQFF	In	VDJ	1	214	0.0016624070722214886	0.002206526782492138	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	6	8	4	3	25	38	50	42	53						01,02							Vb 3	CASSSPTSVDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGAGGGCAGGGTGGGAGATACGCAGTATTTTGGCCCA	CASKEGRVGDTQYF	In	VDJ	1	235	0.0018255404765049057	0.0024230551116151983	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	0	5	1	9	25	35	42	36	51													Vb 3	CASKEGRVGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTCGCGGGAGATCAATGGAAATCCACAGATACGCAGTATTTTGGCCCA	CASSFVAGDQWKSTDTQYF	In	VDJ	1	242	0.0018799182779327113	0.002495231221322885	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	2	4	13	24	38	49	42	62													Vb 3	CASSFVAGDQWKSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACTGGAAGGAATGAGCAGTTCTTCGGGCCA	CASSLTGRNEQFF	In	VDJ	2	254	0.001973137366094664	0.002618961695107491	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	2	1	8	7	3	3	25	40	46	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLTGRNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTTGGTGGGTCAAGAGATACGCAGTATTTTGGCCCA	CASSLGGSRDTQYF	In	VDJ	2	255	0.0019809056234414936	0.0026292725679228747	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	5	0	9	5	6	5	25	37	46	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGSRDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTACCTACGAGCAGTACTTCGGGCCG	CASSLGTYEQYF	In	VDJ	2	260	0.0020197469101756404	0.0026808269319997936	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	2	0	2	25	-1	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCTGAAAGGAGATACAATGAGCAGTTCTTCGGGCCA	CASSLPERRYNEQFF	In	VDJ	2	274	0.0021285025130312516	0.0028251791514151674	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	2	4	7	1	25	40	51	47	52													Vb 3	CASSLPERRYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGACACGTACGAGCAGTACTTCGGGCCG	CASSPDTYEQYF	In	VDJ	2	291	0.0022605628879273513	0.0030004639892766923	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	4	4	2	25	36	44	40	46													Vb 3	CASSPDTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGCCGGAGACAACCAAGAGACCCAGTACTTCGGGCCA	CASSWAGDNQETQYF	In	VDJ	2	296	0.002299404174661498	0.0030520183533536112	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	4	2	6	0	8	0	25	38	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSWAGDNQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCTCAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQAYNEQFF	In	VDJ	2	387	0.0030063155932229723	0.003990307779553539	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	4	2	3	0	25	34	-1	37	41													Vb 3	CASSQAYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGCCTAGCGGGAGGGATAATGAGCAGTTCTTCGGGCCA	CASSLLPSGRDNEQFF	In	VDJ	7	1182	0.009182080183952335	0.012187451667783678	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	0	7	3	2	25	41	56	44	58													Vb 3	CASSLLPSGRDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCAGCGGACCCTTACAATGAGCAGTTCTTCGGGCCA	CASSFSADPYNEQFF	In	VDJ	14	2213	0.01719115350853343	0.0228179615404444	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	4	3	5	25	39	47	42	52						01,02							Vb 3	CASSFSADPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCACTCAACGGGGGCGGGGGAACACTGAAGCTTTCTTTGGACAA	CATQRGRGNTEAFF	In	VDJ	1	131	0.0010176417124346496	0.0013507243388152807	42	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-01	01	12	6	0	1	8	4	18	23	37	31	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQRGRGNTEAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAGGGATACGCAGTATTTTGGCCCA	CASSQDRDTQYF	In	VDJ	1	50	3.884128673414693E-4	5.155436407691911E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-03	01	0	5	4	6	1	0	23	40	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGCTTCACATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	4.272541540756162E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	6	0	5	0	23	39	-1	44	47														X+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCGGGAACACTGAAGCTTTCTTTGGACAA	CASSQAGNTEAFF	In	VDJ	1	80	6.214605877463508E-4	8.248698252307058E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	1	1	0	23	39	-1	40	43						01,02								CASSQAGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCCACATGCGACTAGCCCCATTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLHMRLAPLSSYNEQFF	In	VDJ	1	163	0.0012662259475331899	0.0016806722689075631	60	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	7	0	9	9	21	34	50	43	59						01,02								CASSLHMRLAPLSSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAGAAGGGGGGCAGGGCCGTCCCTACGAGCAGTACTTCGGGCCG	CSAEGGQGRPYEQYF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	7	5	1	2	4	11	25	32	42	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAEGGQGRPYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGGGGCAGAGACTGAAGCTTTCTTTGGACAA	CSVQGAETEAFF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	5	0	4	25	-1	42	34	46													Vb 4	CSVQGAETEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCTCCGTTTTGTAGGGGATACGCAGTATTTTGGCCCA	CSVVLRFVGDTQYF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	5	3	6	13	0	25	35	-1	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVLRFVGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGACACAGGGGCTGACACAGATACGCAGTATTTTGGCCCA	CSADTGADTDTQYF	In	VDJ	1	49	3.806446099946399E-4	5.052327679538073E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	2	2	5	4	25	32	44	37	48													Vb 4	CSADTGADTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCTGTCGGATTCAGATACGCAATATTTTGGCCCA	CSALSDSDTQYF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	7	1	8	15	7	13	25	32	42	39	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSALSDSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTACCCATACGTGGACATGGAAAATCAAGATGGCTACACCTTCGGTTCG	CSVYPYVDMENQDGYTF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	6	11	12	25	34	50	45	62													Vb 4	CSVYPYVDMENQDGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGAGAGTATGGGACGGACAACTATGGCTACACCTTCGGTTCG	CSVGEYGTDNYGYTF	In	VDJ	1	64	4.971684701970807E-4	6.598958601845646E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	6	0	7	2	10	4	25	33	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGEYGTDNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAGAACGGGGGACACTGAAGCTTTCTTTGGACAA	CSVRTGDTEAFF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	3	5	0	25	33	-1	38	44													Vb 4	CSVRTGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACTACCGGGGACTCCAATGTCCTGACTTTCGGGGCC	CSVTTGDSNVLTF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	0	10	13	7	5	25	34	47	41	52						01,02							Vb 4	CSVTTGDSNVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTGGGACAGGGGTTGAACATTCAGTACTTCGGCGCC	CSVLGQGLNIQYF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	2	7	2	3	25	34	46	36	49													Vb 4	CSVLGQGLNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSVGAGSSYNEQFF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	0	2	2	25	35	43	37	45													Vb 4	CSVGAGSSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCGACAGGGTACACTGAAGCTTTCTTTGGACAA	CSVATGYTEAFF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	3	3	1	25	33	43	36	44													Vb 4	CSVATGYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGAAGGGGGCGCGGGCTGAAGCTTTCTTTGGACAA	CSVKGARAEAFF	In	VDJ	1	74	5.748510436653745E-4	7.630045883384028E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	6	2	5	25	33	42	35	47													Vb 4	CSVKGARAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAGACAGGCAAGAGACCCAGTACTTCGGGCCA	CSVADRQETQYF	In	VDJ	1	78	6.059240730526921E-4	8.042480795999381E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	2	0	0	25	-1	-1	39	43													Vb 4	CSVADRQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAACGGGACTAGCGGGACCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	85	6.603018744804977E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	3	4	4	3	25	34	51	38	54													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGTCGTAGGGCCTAAGAGAGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	96	7.457527052956211E-4		50	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	2	5	3	4	6	11	25	37	47	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCACTAGGGACAGGGAAATGGCTACACCTTCGGTTCG		Out	VDJ	1	112	8.700448228448912E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	6	8	2	25	32	49	40	51													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGACAGGGACCACCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	128	9.943369403941614E-4		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	1	0	6	25	-1	43	36	49													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCCCCTACATGCGGGAGGGGGACAATGAGCAGTTCTTCGGGCCA	CSVLPYMREGDNEQFF	In	VDJ	1	129	0.0010021051977409908	0.0013301025931845131	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	0	5	11	2	25	34	54	45	56													Vb 4	CSVLPYMREGDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCAGGGCCCGGTCAGCCCCAGCATTTTGGTGAT	CSVSGPGQPQHF	In	VDJ	1	162	0.0012584576901863605	0.0016703613960921792	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	6	1	5	25	34	40	35	45													Vb 4	CSVSGPGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAAGACAGCAGCATATATCTCTGCAGCGTTCTACCTTACGCCGGGACTAGCGGGATTGTTCTCACAGATACGCAGTATTTTGGCCCA	CSVLPYAGTSGIVLTDTQYF	In	VDJ	1	170	0.0013206037489609955	0.0017528483786152498	60	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	3	2	12	7	21	30	55	42	62													Vb 4	CSVLPYAGTSGIVLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCGAACAGGGGGCGTATGGCTACACCTTCGGTTCG	CSVLEQGAYGYTF	In	VDJ	1	176	0.001367213293041972	0.0018147136155075526	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	5	5	1	25	34	48	39	49													Vb 4	CSVLEQGAYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGGACTTCCAGAGGCTGATACGCAGTATTTTGGCCCA	CSVDGLPEADTQYF	In	VDJ	1	191	0.0014837371532444128	0.00196937670773831	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	10	6	1	10	25	36	42	37	52						01,02							Vb 4	CSVDGLPEADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCACTCGAACAGGGGGCTCATGGCTACACCTTCGGTTCG	CSALEQGAHGYTF	In	VDJ	1	193	0.0014992736679380714	0.0019899984533690777	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	0	6	7	2	25	32	48	39	50													Vb 4	CSALEQGAHGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAATACTGGGGGGGAGACGACTGAAGCTTTCTTTGGACAA	CSVNTGGETTEAFF	In	VDJ	1	201	0.0015614197267127066	0.002072485435892148	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	5	7	5	25	33	47	40	52													Vb 4	CSVNTGGETTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGTTTAGCGGGAGTCCACAATGAGCAGTTCTTCGGGCCA	CSVGLAGVHNEQFF	In	VDJ	1	225	0.0017478579030366119	0.00231994638346136	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	5	5	3	25	33	47	38	50													Vb 4	CSVGLAGVHNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTGAATCAGGGTCCCACTGAAGCTTTCTTTGGACAA	CSVLNQGPTEAFF	In	VDJ	1	240	0.0018643817632390525	0.0024746094756921172	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	4	7	3	25	33	45	40	48													Vb 4	CSVLNQGPTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGCTTTTTGGGGCAAGGCTACGAGCAGTACTTCGGGCCG	CSVRFLGQGYEQYF	In	VDJ	2	263	0.0020430516822161284	0.002711759550445945	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	3	8	4	25	34	47	42	51													Vb 4	CSVRFLGQGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCTAGGGACTTCGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVARDFDSGANVLTF	In	VDJ	2	265	0.002058588196909787	0.002732381296076713	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	0	10	0	5	4	25	33	44	38	48						01,02							Vb 4	CSVARDFDSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGACAGGGGTAGCTGAAGCTTTCTTTGGACAA	CSVRTGVAEAFF	In	VDJ	2	311	0.002415928034863939	0.0032066814455843687	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	6	2	3	25	33	44	35	47													Vb 4	CSVRTGVAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTTGGCCCTAACCGGGGAGCTGTTTTTTGGAGAA	CSALALTGELFF	In	VDJ	2	373	0.0028975599903673607	0.0038459555601381657	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	7	9	0	5	4	4	25	32	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSALALTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCCCGCGGGAGTGGGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	512	0.0039773477615766455		46	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	2	3	5	6	25	37	49	42	55													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAACAACTCGAACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	522	0.004055030335044939		44	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	0	3	6	2	0	7	25	-1	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGTTTATGCAGGGGCCAATTCGGGTACAGATACGCAGTATTTTGGCCCA	CSVDVYAGANSGTDTQYF	In	VDJ	7	1083	0.008413022706616225	0.01116667525906068	54	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	3	8	11	25	36	50	44	61													Vb 4	CSVDVYAGANSGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTTCCTTATTCCACGGGAGGGAAAGTATCCTACGAGCAGTACTTCGGGCCG	CSVLPYSTGGKVSYEQYF	In	VDJ	8	1366	0.010611439535768942	0.0140846522658143	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	0	1	13	6	25	34	55	47	61													Vb 4	CSVLPYSTGGKVSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGTTACCCTATTTAGCGGGAGGTCAAACAGATACGCAGTATTTTGGCCCA	CSVLPYLAGGQTDTQYF	In	VDJ	10	1585	0.012312687894724577	0.01634273341238336	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	1	3	11	4	25	33	54	44	58													Vb 4	CSVLPYLAGGQTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGCCATACAGATACGCAGTATTTTGGCCCA	YASSHTDTQYF	In	VDJ	1	97	7.535209626424504E-4	0.0010001546630922307	33	TCRBV26	TCRBV26-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	6	3	1	1	27	38	41	39	42														YASSHTDTQYF+TCRBV26-01+TCRBJ02-03	TCRBV26-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCCCGTTCGACAGGGGGCCGGCGGGACGTTGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	3.6510809530098114E-4		59	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	4	8	14	22	34	52	42	66		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCACAGGGACGGGCGATAACAGATACGCAGTATTTTGGCCCA	CASSPQGRAITDTQYF	In	VDJ	1	49	3.806446099946399E-4	5.052327679538073E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	3	3	10	23	34	43	37	53		TCRBV06-07,TCRBV06-08												CASSPQGRAITDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCTACAGGGAATAGGCGGGGAGCTGTTTTTTGGAGAA	CASSLQGIGGELFF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	7	3	6	23	34	43	37	49		TCRBV06-07,TCRBV06-08												CASSLQGIGGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAAGGAGGACCCTTTACGAGCAGTACTTCGGGCCG	CASSLRRTLYEQYF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	1	4	1	6	18	33	39	34	45		TCRBV11-01,TCRBV11-03												CASSLRRTLYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCTTTTGGACTCTTTAAGGGATCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	5.204732422375689E-4		44	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	1	10	2	4	12	26	32	41	36	53		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTGGGACAGGGTGGAAATGAAAAACTGTTTTTTGGCAGT	CASSLGQGGNEKLFF	In	VDJ	1	67	5.204732422375689E-4	6.908284786307161E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	5	0	4	18	-1	41	32	45		TCRBV07-06,TCRBV07-07												CASSLGQGGNEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATTTCGCGGGAGTAGGATATACGCAGTATTTTGGCCCA	CASSYFAGVGYTQYF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	7	4	6	23	37	48	41	54		TCRBV06-07,TCRBV06-08												CASSYFAGVGYTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
SGACTCRGCYRTGTATCKCTGTGCCGCTTGCCATTGACAGGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	70	5.43778014278057E-4		40	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	4	2	10	1	19	25	41	35	42		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGACAACCCACCGGACTTCCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	78	6.059240730526921E-4		47	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	1	10	2	10	3	26	37	52	47	55		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCATTGTAGCGGGCATTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	94	7.302161906019623E-4		44	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	5	4	1	3	4	23	33	43	36	47		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCAAGGAGGAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGGGSGANVLTF	In	VDJ	1	108	8.389717934575736E-4	0.0011135742640614528	48	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	1	0	3	3	18	30	38	33	41		TCRBV11-01,TCRBV11-03												CASSQGGGSGANVLTF+TCRBV11-X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGCGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSEAGGTDTQYF	In	VDJ	1	149	0.0011574703446775784	0.0015363200494921895	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	1	0	0	23	-1	-1	40	45		TCRBV06-01,TCRBV06-04												CASSEAGGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCCCACGGGACAGGGCTCCCCTATGGGGTACGCAGTATTTTGGCCCA	CASPRDRAPLWGTQYF	In	VDJ	1	154	0.0011963116314117255	0.0015878744135691086	48	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	8	4	13	26	35	48	39	61		TCRBV10-01,TCRBV10-02												CASPRDRAPLWGTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGAGGACTAGCGGGAGTCTCAACGAGCAGTACTTCGGGCCG	CASRRTSGSLNEQYF	In	VDJ	1	158	0.0012273846607990429	0.0016291179048306438	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	2	5	2	5	23	34	49	36	54		TCRBV06-07,TCRBV06-08												CASRRTSGSLNEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCACCAGCAGCAGCTCTAGGGCGGGTGATACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	173	0.0013439085210014837		47	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	3	10	5	26	37	52	47	57		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAATCGTGTCGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	185	0.0014371276091634363		46	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	3	9	0	2	8	1	28	42	53	50	54		TCRBV06-01,TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGCCATCGCCTAGCAGGTTCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	193	0.0014992736679380714		50	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	7	3	7	7	26	41	53	48	60		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCAAAACAGAAGAAGAGACCCAGTACTTCGGGCCA	CASSKTEEETQYF	In	VDJ	1	201	0.0015614197267127066	0.002072485435892148	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	5	3	3	3	18	30	37	33	40		TCRBV07-01,TCRBV07-02												CASSKTEEETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGTGGCGGGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSEVAGGTGELFF	In	VDJ	1	228	0.0017711626750770999	0.0023508790019075116	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	7	1	5	2	1	23	39	49	41	50		TCRBV06-01,TCRBV06-04												CASSEVAGGTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGGTACCTGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	243	0.0018876865352795407		38	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	9	6	2	0	6	0	26	34	-1	40	44		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRGGTDTQYF	In	VDJ	3	428	0.0033248141444429773	0.004413053564984276	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	1	3	1	0	18	30	-1	31	39		TCRBV07-01,TCRBV07-02												CASSRGGTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAACACCCTGGCCGGGGGGCTCGCAGATACGCAGTATTTTGGCCCA	CANTLAGGLADTQYF	In	VDJ	4	608	0.004723100466872267	0.006269010671753364	45	TCRBV12	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	1	4	12	4	26	31	50	43	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CANTLAGGLADTQYF+TCRBV12-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCCTAATAGGGGACCCCACAGATACGCAGTATTTTGGCCCA	CASTLIGDPTDTQYF	In	VDJ	7	1174	0.0091199341251777	0.012104964685260608	45	TCRBV12	unresolved					TCRBJ02	TCRBJ02-03	01	12	0	7	2	14	2	26	31	50	45	52		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLIGDPTDTQYF+TCRBV12-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGAGACAGGGGGAAGACCCGGGGAGCTGTTTTTTGGAGAA	CASSETGGRPGELFF	In	VDJ	1	187	0.0014526641238570951	0.0019281332164767747	45	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	1	6	2	5	22	34	45	36	50														CASSETGGRPGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGACAGTCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESGQSYSNQPQHF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	5	0	0	5	23	-1	47	40	52													Vb 12	CASSESGQSYSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAAGACGGGATCGGCACAGATACGCAGTATTTTGGCCCA	CASKDGIGTDTQYF	In	VDJ	1	122	9.477273963131851E-4	0.0012579264834768262	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	8	3	1	4	3	23	33	42	37	45													Vb 12	CASKDGIGTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCGGGACTCTCGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSSGTLGSNTEAFF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	1	2	8	27	40	48	42	56			01,02			01,02							Vb 17	CASSSGTLGSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTTAGCGCCCGAGCAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	50	3.884128673414693E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	6	6	2	9	27	39	46	41	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCTACCCTGGAAGACAGGCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	51	3.9618112468829865E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	4	2	12	2	27	40	58	52	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCGTATACAGTAATAATCACCCCCAGCATTTTGGTGAT	CASSFVYSNNHPQHF	In	VDJ	1	51	3.9618112468829865E-4	5.258545135845749E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	5	10	7	10	27	39	50	46	60			01,02										Vb 17	CASSFVYSNNHPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATACGCGTGGGGTGGCAATGAGCAGTTCTTCGGGCCA	CASSIYAWGGNEQFF	In	VDJ	1	57	4.4279066876927497E-4	5.877197504768779E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	6	2	6	7	3	27	42	53	49	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYAWGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCCAAAGCGGGAGGCGTTTGGATACGCAGTATTTTGGCCCA	CASSFQSGRRLDTQYF	In	VDJ	1	59	4.583271834629338E-4	6.083414961076455E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	1	6	6	6	27	39	54	45	60			01,02										Vb 17	CASSFQSGRRLDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCACCTAAGGCAGTCGGGGGCAGCCCAATGAGCAGTTCTTCGGGCCA	CASTT*GSRGQPNEQFF	Stop	VDJ	1	61	4.7386369815659253E-4		51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	6	0	6	15	4	27	37	58	52	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTT*GSRGQPNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCCCGCCAAGCCCTATGGCTACACCTTCGGTTCG	CASSAPAKPYGYTF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	6	7	4	10	1	27	39	52	49	53			01,02			01,02							Vb 17	CASSAPAKPYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAAGGCTAGGGGCAGGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	73	5.670827863185451E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	2	13	0	27	39	-1	52	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGGAGGACTAGCCCACGAGCAGTACTTCGGGCCG	CASSSGGLAHEQYF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	7	5	6	2	27	39	53	45	55			01,02			01,02							Vb 17	CASSSGGLAHEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGGGGACTACCTAACTATGGCTACACCTTCGGTTCG	CASSIEGGLPNYGYTF	In	VDJ	1	74	5.748510436653745E-4	7.630045883384028E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	9	0	6	1	27	41	54	47	55			01,02			01,02							Vb 17	CASSIEGGLPNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGACCCGCCATGACAGGGACATTCAGTACTTCGGCGCC		Out	VDJ	1	75	5.826193010122039E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	2	3	8	12	0	27	34	-1	46	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGACTAGCGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	80	6.214605877463508E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	4	2	1	27	39	51	41	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGAGGGAGGGCCTCCATGAGCAGTTCTTCGGGCCA	CASTREGLHEQFF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	9	0	8	3	5	27	37	47	40	52			01,02										Vb 17	CASTREGLHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCAGGGGGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	86	6.680701318273271E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	5	4	1	1	2	2	27	39	48	41	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSITGLNTEAFF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	0	0	1	27	-1	48	42	49			01,02										Vb 17	CASSITGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGACAGACCATTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	91	7.069114185614741E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	5	0	1	7	27	36	42	37	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACAGACAGTTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTDSLNTGELFF	In	VDJ	1	94	7.302161906019623E-4	9.692220446460793E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	5	1	2	3	27	37	44	39	47			01,02										Vb 17	CASTDSLNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTCCCCCCGGGAGATCAGCCCCAGCATTTTGGTGAT	CASSIFPPGDQPQHF	In	VDJ	1	97	7.535209626424504E-4	0.0010001546630922307	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	2	5	8	0	27	41	-1	49	55			01,02										Vb 17	CASSIFPPGDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAAAAGACGGCGGGGGCCCGTTGGCATTTTGGTGAT	CASSQKTAGARWHF	In	VDJ	1	105	8.156670214170855E-4	0.0010826416456153013	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	2	15	9	7	27	39	55	48	62			01,02										Vb 17	CASSQKTAGARWHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTAGCGGGAGTTGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	111	8.622765654980618E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	2	9	0	5	27	-1	55	43	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCGGGCAGCGGGAGAGGAAATGAGCAGTTCTTCGGGCCA	CASSIPGSGRGNEQFF	In	VDJ	1	124	9.632639110068439E-4	0.001278548229107594	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	7	6	4	27	42	56	48	60			01,02										Vb 17	CASSIPGSGRGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTTGGGGGGTGAGCAGTTCTTCGGGCCA	CASSPLGGEQFF	In	VDJ	1	124	9.632639110068439E-4	0.001278548229107594	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	9	5	0	27	39	-1	44	50			01,02										Vb 17	CASSPLGGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTAGCGGGAGGGCCGGAGCTCCTACGAGCAGTACTTCGGGCCG	CAS*REGRSSYEQYF	Stop	VDJ	1	129	0.0010021051977409908		45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	4	0	0	0	6	27	-1	47	35	53			01,02										Vb 17	CAS*REGRSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGATAGCGGGAGTGGGGCTGGAGACCCAGTACTTCGGGCCA	CASSKIAGVGLETQYF	In	VDJ	1	132	0.001025409969781479	0.0013610352116306646	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	2	5	3	8	27	40	52	43	60			01,02										Vb 17	CASSKIAGVGLETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGGGCTAGCGGGAGCCTCTACAGTTCTTCGGGCCA		Out	VDJ	1	136	0.0010564829991687964		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	13	2	6	27	43	55	45	61			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGAGGGACGGGACTAGCGGCACGGGCAGTTCTTCGGGCCA	CASSPEGRD*RHGQFF	Stop	VDJ	1	146	0.0011341655726370902		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	12	10	5	27	39	60	49	65			01,02			01,02							Vb 17	CASSPEGRD*RHGQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSINTGELFF	In	VDJ	1	147	0.0011419338299839196	0.001515698303861422	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	6	2	2	2	27	36	40	38	42			01,02										Vb 17	CASSINTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCCAGGACAGGGGTCGAGCAGTACTTCGGGCCG	CASSARTGVEQYF	In	VDJ	1	152	0.0011807751167180666	0.001567252667938341	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	6	5	1	27	38	52	43	53			01,02										Vb 17	CASSARTGVEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCCGGGGGGCGCGGACTGAAGCTTTCTTTGGACAA	CASSIGRGARTEAFF	In	VDJ	1	159	0.0012351529181458723	0.0016394287776460277	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	1	5	2	5	27	43	52	45	57			01,02										Vb 17	CASSIGRGARTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCACCCGCTCACAATGAGCAGTTCTTCGGGCCA	CASNPPAHNEQFF	In	VDJ	1	190	0.0014759688958975834	0.0019590658349229262	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	7	3	7	5	0	10	27	-1	39	37	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNPPAHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAGGCAGGGGGCGCTTTAGATACGCAGTATTTTGGCCCA	CASSEAGGALDTQYF	In	VDJ	1	210	0.001631334042834171	0.0021652832912306026	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	5	5	5	27	38	51	43	56			01,02										Vb 17	CASSEAGGALDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTGTCGGCAGGGTCAGATACGCAGTATTTTGGCCCA	CASSIDLSAGSDTQYF	In	VDJ	1	213	0.0016546388148746592	0.002196215909676754	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	4	8	1	27	44	57	52	58			01,02										Vb 17	CASSIDLSAGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCGGATTCTATGGCTACACCTTCGGTTCG	CASSIAGFYGYTF	In	VDJ	1	230	0.0017866991897707587	0.002371500747538279	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	1	8	4	2	2	27	43	48	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCAGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSARVSNQPQHF	In	VDJ	2	252	0.001957600851401005	0.0025983399494767232	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	0	2	1	27	39	46	41	47			01,02										Vb 17	CASSARVSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATCAGTAATTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	299	0.0023227089467019865		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	5	0	2	6	27	38	43	40	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAACGAAGACCCATCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	335	0.002602366211187844		49	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	6	2	7	0	7	6	27	38	48	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGACTAGCGGTTTGGGGGAGACCCAGTACTTCGGGCCA	CASSPGTSGLGETQYF	In	VDJ	2	353	0.002742194843430773	0.0036397381038304893	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	5	3	7	27	39	53	42	60			01,02			01,02							Vb 17	CASSPGTSGLGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACAACTCTCGGGGGCTCTTCTGATACGCAGTATTTTGGCCCA	CATTLGGSSDTQYF	In	VDJ	2	356	0.0027654996154712615	0.003670670722276641	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	10	6	0	6	8	6	27	34	48	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATTLGGSSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCATAAAGTCGACAGGATGAGCACTGAAGCTTTCTTTGGACAA	CASHKVDRMSTEAFF	In	VDJ	3	452	0.0035112523207668825	0.004660514512553488	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	4	4	10	5	27	35	51	45	56			01,02										Vb 17	CASHKVDRMSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTCGGGAGGGGCAGGTTACACAGATACGCAGTATTTTGGCCCA	CASRSGGAGYTDTQYF	In	VDJ	3	480	0.003728763526478105	0.0049492189513842344	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	0	2	2	8	27	38	48	40	56			01,02										Vb 17	CASRSGGAGYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGCCCGGGACAGGTCCACCTCGGGCAGTTCTTCGGGCCA	CASSISPGQVHLGQFF	In	VDJ	4	664	0.005158122878294712	0.006846419549414858	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	4	12	6	10	27	41	55	47	65			01,02										Vb 17	CASSISPGQVHLGQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAGATAGAGCGGGAGTGGTCCTACGAGCAGTACTTCGGGCCG	CASQIEREWSYEQYF	In	VDJ	5	740	0.005748510436653745	0.0076300458833840285	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	6	2	1	7	3	27	36	51	43	54			01,02										Vb 17	CASQIEREWSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTTATTTGACTAGTTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIFYLTSSGTGELFF	In	VDJ	5	881	0.006843834722556689	0.009083878950353147	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	2	8	4	9	6	27	41	56	50	62			01,02			01,02							Vb 17	CASSIFYLTSSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTACAAGCGGAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	51	3.9618112468829865E-4		56	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01		TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCTGGGGGCGAGGAGACCCAGTACTTCGGGCCA	CASSAGGEETQYF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	6	0	5	2	3	23	36	44	38	47													Vb 11	CASSAGGEETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCGAGGACGGGAGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPRTGGATNEKLFF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	0	0	7	1	23	35	50	42	51													Vb 11	CASSPRTGGATNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCCGGGACTACGAGCAGTACTTCGGGCCG	CASSARDYEQYF	In	VDJ	1	69	5.360097569312276E-4	7.114502242614837E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	3	3	2	0	23	36	-1	38	43													Vb 11	CASSARDYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCCGGGTAGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGSGNTEAFF	In	VDJ	1	113	8.778130801917206E-4	0.001165128628138372	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	1	2	6	23	34	40	36	46						01,02							Vb 11	CASSPGSGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCCTCAGCGGGCAAAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	157	0.0012196164034522137		43	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	6	4	5	5	4	23	33	44	38	48						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTACTCAGGCAAGTCTCAAGAGACCCAGTACTTCGGGCCA	CASYSGKSQETQYF	In	VDJ	1	189	0.001468200638550754	0.0019487549621075423	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	4	2	4	7	23	32	40	36	47													Vb 11	CASYSGKSQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTAGAATACACAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	702	0.005453316657474228		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCGGAAGACAGGGGAGGGACACTGAAGCTTTCTTTGGACAA	CAGRQGRDTEAFF	In	VDJ	1	78	6.059240730526921E-4	8.042480795999381E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	2	3	4	4	23	29	41	33	45													Vb 22	CAGRQGRDTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGGCAGGGAGGGGCTACGAGCAGTACTTCGGGCCG	CASGAGRGYEQYF	In	VDJ	1	147	0.0011419338299839196	0.001515698303861422	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	9	0	3	6	1	23	32	45	38	46													Vb 22	CASGAGRGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATRGGGGAAGCGGGAGGGCCAAAGATACGCAGTATTTTGGCCCA	CASSDXGSGRAKDTQYF	In	VDJ	1	186	0.0014448958665102657	0.001917822343661391	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	0	5	7	4	23	37	54	44	58													Vb 22	CASSDXGSGRAKDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGAGGGGTGGGACGAGATAAATGAGCAGTTCTTCGGGCCA	CASEGWDEINEQFF	In	VDJ	5	770	0.005981558157058627	0.007939372067845544	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-01	01	8	0	7	7	7	6	23	32	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASEGWDEINEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGTCTAACAAACTATCGGACAGATGGGGCACTACGAGCAGTACTTCGGGCCG	CASSV*QTIGQMGHYEQYF	Stop	VDJ	1	90	6.991431612146448E-4		57	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	5	3	14	8	24	37	57	51	65			01,02											CASSV*QTIGQMGHYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCTTAACCCCGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	62	4.8163195550342193E-4		46	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-01	01	2	1	8	1	9	0	26	41	-1	50	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSYGTANYGYTF	In	VDJ	1	100	7.768257346829386E-4	0.0010310872815383822	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	0	0	0	26	-1	-1	41	48														CASSYGTANYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGATTGGATTTTGCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	129	0.0010021051977409908		47	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	0	1	8	5	4	6	26	43	50	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGACCGGGAGGGAGGTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	188	0.0014604323812039246		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	0	3	5	5	26	38	51	43	56														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCAATTTAGCCGTTAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	86	6.680701318273271E-4		53	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	5	7	5	4	13	28	40	48	44	61			01,02			01,02								X+TCRBV16-01+TCRBJ02-06	TCRBV16-01	TCRBD02-01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCTGTCAATCAGCCCCAGCATTTTGGTGAT	CASSQSVNQPQHF	In	VJ	3	560	0.004350224114224456	0.00577408877661494	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-05	01	0	0	0	3	0	3	29	-1	46	-1	49			01,02											CASSQSVNQPQHF+TCRBV16-01+TCRBJ01-05	TCRBV16-01		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTCTCTGATAGCGGGAAGGGGGAATGAGCAGTTCTTCGGGCCA	CASSSLIAGRGNEQFF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	7	7	6	23	35	50	42	56	TCRBV01,TCRBV04													CASSSLIAGRGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTCTCAGCGGACCCTTACAATGAGCAGTTCTTCGGGCCA	CASSFSADPYNEQFF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	4	3	5	36	50	58	53	63	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01				01,02								CASSFSADPYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CACCAACCAGACMTCTMTGTACYTCTGTGCCAGCAGTCCGGGGCCCTCCGGCCTCTATGGCTACACCTTCGGTTCG	CASSPGPSGLYGYTF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	7	0	4	2	10	25	37	44	39	54	TCRBV27,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPSGLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCGGAACGACGGACCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	3.6510809530098114E-4		49							TCRBJ02	TCRBJ02-07	01	0	1	7	2	10	1	18	35	49	45	50	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07			TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAATACCGGGACTAGCGGACTCACAGATACGCAGTATTTTGGCCCA	CSANTGTSGLTDTQYF	In	VDJ	1	48	3.7287635264781054E-4	4.949218951384235E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	2	7	3	26	34	52	41	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSANTGTSGLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTGAAGGGCGGGCCCCCCTCCTCCAGTACTTCGGGCCA	CASIEGRAPLLQYF	In	VDJ	1	49	3.806446099946399E-4	5.052327679538073E-4	42	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	7	4	10	1	10	23	39	45	40	55		TCRBV06-01,TCRBV06-08				01,02								CASIEGRAPLLQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCCGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVAGSSYNEQFF	In	VDJ	1	49	3.806446099946399E-4	5.052327679538073E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-01	01	0	1	8	0	2	2	23	39	44	41	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVAGSSYNEQFF+X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTCGTTTCCCCTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	50	3.884128673414693E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLSRTGELFF	In	VDJ	1	50	3.884128673414693E-4	5.155436407691911E-4	39							TCRBJ02	TCRBJ02-02	01	6	5	4	5	6	0	24	36	-1	42	45	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGACAGGGTCATGGCTACACCTTCGGTTCG	CSAPRQGHGYTF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	6	4	2	26	35	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSAPRQGHGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTGACAGGGATTCTTAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	4.0394938203512805E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	0	2	8	26	33	42	35	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGGCCGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVGPTNTGELFF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	8	0	0	2	3	26	33	39	35	42		TCRBV20-01,TCRBV20-or09_02												CSVGPTNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCAGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRYSNQPQHF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	5	0	0	3	22	-1	36	33	39		TCRBV12-03,TCRBV12-04												CASSRYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGAAGCTTGCGGGATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	52	4.0394938203512805E-4		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	3	0	0	2	18	-1	38	33	40	TCRBV05,TCRBV07													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGGCCCTCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	4.0394938203512805E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	1	1	5	18	32	37	33	42	TCRBV05,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCTCACTCCGGATTACCAAACACTGAAGCTTTCTTTGGACAA	CASSPHSGLPNTEAFF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	4	1	8	2	9	6	23	35	47	44	53	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPHSGLPNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAGTCTCCCGGGACAGGGCAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	53	4.1171763938195746E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	4	10	3	26	38	57	48	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAATTACATGGACACTGAAGCTTTCTTTGGACAA	CASSNYMDTEAFF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	6	3	5	3	26	37	45	42	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSNYMDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGGGACCCCTCCCGCAATGAGCAGTTCTTCGGGCCA	CASSRDPSRNEQFF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	0	7	6	1	8	26	38	44	39	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDPSRNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGCGGGCTCCCTGGAGTTCTTCGGGCCA	CASSLAGSLEFF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	14	1	8	26	38	46	39	54		TCRBV03-01,TCRBV03-02				01,02								CASSLAGSLEFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGACTTCCGACACAGATACGCAGTATTTTGGCCCA	CSARSTSDTDTQYF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	2	2	5	26	38	44	40	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSTSDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCACCTAGGGGGGCAGGAGAACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASST*GGRRTSGANVLTF	Stop	VDJ	1	54	4.194858967287868E-4		57	TCRBV12						TCRBJ02	TCRBJ02-06	01	6	5	1	0	5	10	24	35	46	40	56		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASST*GGRRTSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCTACCGTGAGGACACTGAAGCTTTCTTTGGACAA	CASYREDTEAFF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	11	1	3	6	0	23	32	-1	38	42	TCRBV02,TCRBV09													CASYREDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCCAGCGGGGACGGGGACTATGGCTACACCTTCGGTTCG	CASSPSGDGDYGYTF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	6	3	3	3	6	23	35	45	38	51	TCRBV09,TCRBV21													CASSPSGDGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATGGGACTAGCGGGACTCGTTACGCAGTATTTTGGCCCA	CASSMGLAGLVTQYF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	3	8	2	5	26	38	53	40	58		TCRBV12-03,TCRBV12-04												CASSMGLAGLVTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTCGGGCTATTCCTACGAGCAGTACTTCGGGCCG	CASSSGYSYEQYF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	8	0	1	1	3	26	39	44	40	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGYSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGACAGGGGCCTCGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	56	4.350224114224456E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	4	2	8	26	42	52	44	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGGGGATGAACTGAAGCTTTCTTTGGACAA	CSARDQGG*TEAFF	Stop	VDJ	1	56	4.350224114224456E-4		42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	5	3	4	26	40	49	43	53		TCRBV20-01,TCRBV20-or09_02												CSARDQGG*TEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGACACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARDRTPNTGELFF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	6	0	2	1	26	40	47	42	48		TCRBV20-01,TCRBV20-or09_02												CSARDRTPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGCGGGACTAGTGTCGGTTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	4.350224114224456E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	9	2	7	18	35	45	37	52	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGGGACAGGGTGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	56	4.350224114224456E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	4	1	4	18	34	44	35	48	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGGGGACTCRGCYSTSTATCTCTGTGCCAGCAGCTTCCGGGACAGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	56	4.350224114224456E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	2	2	1	22	36	46	38	47	TCRBV05,TCRBV07													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATCCGGGACTAGCGGGGACCTACGAGCAGTACTTCGGGCCG	CASNPGLAGTYEQYF	In	VDJ	1	57	4.4279066876927497E-4	5.877197504768779E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	0	3	2	7	1	24	31	51	38	52		TCRBV24-01,TCRBV24-or09_02												CASNPGLAGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTCGACAGTGTGGCTGGCTACACCTTCGGTTCG	CASSVDSVAGYTF	In	VDJ	1	57	4.4279066876927497E-4	5.877197504768779E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	7	2	6	23	36	43	38	49	TCRBV02,TCRBV12													CASSVDSVAGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGACTAGAGGGGGATACGCAGTATTTTGGCCCA	CASSLGLEGDTQYF	In	VDJ	1	58	4.5055892611610437E-4	5.980306232922617E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	8	6	1	5	26	39	48	40	53		TCRBV03-01,TCRBV03-02				01,02								CASSLGLEGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCCCCCCTCGGGGGGCCGGGGGGTTTAACACTGAAGCTTTCTTTGGACAA	CASPPRGAGGFNTEAFF	In	VDJ	1	58	4.5055892611610437E-4	5.980306232922617E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	1	2	6	11	23	32	45	38	56	TCRBV09,TCRBV12													CASPPRGAGGFNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCCGAGAAGCAATCAGCCCCAGCATTTTGGTGAT	CSASPPRSNQPQHF	In	VDJ	1	59	4.583271834629338E-4	6.083414961076455E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	2	1	6	1	26	37	46	43	47		TCRBV20-01,TCRBV20-or09_02												CSASPPRSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGACAGCGGGGGGAATGTACGAGCAGTACTTCGGGCCG	CATSDPTAGGMYEQYF	In	VDJ	1	59	4.583271834629338E-4	6.083414961076455E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	1	4	5	4	24	39	53	44	57		TCRBV24-01,TCRBV24-or09_02												CATSDPTAGGMYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGGCGGTACACTGAAGCTTTCTTTGGACAA	CASSPRRYTEAFF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	5	3	4	1	26	39	47	43	48		TCRBV03-01,TCRBV03-02				01,02								CASSPRRYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCAGGCAGGCGATCGAACACTGAAGCTTTCTTTGGACAA	CSASSGRRSNTEAFF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	2	9	26	37	43	39	52		TCRBV20-01,TCRBV20-or09_02												CSASSGRRSNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCGACAGAAGGGAGAGCCCTACGAGCAGTACTTCGGGCCG	CASSRQKGEPYEQYF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	6	2	5	2	2	10	22	33	40	35	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRQKGEPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGAGCCGGACAGGGAATTAACTGAAGCTTTCTTTGGACAA	CASSLEPDRELTEAFF	In	VDJ	1	60	4.660954408097631E-4	6.186523689230293E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	5	6	5	18	32	46	38	51	TCRBV07,TCRBV11													CASSLEPDRELTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCCAGCGGAACAATGAGCAGTTCTTCGGGCCA	CSARDIQRNNEQFF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	5	5	5	1	26	40	50	45	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDIQRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCTAGGGGGTCGGGGACAGCCCCAGCATTTTGGTGAT	CSAALGGRGQPQHF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	7	5	7	26	35	46	40	53		TCRBV20-01,TCRBV20-or09_02												CSAALGGRGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTGGACAGGGTTGGGTGGCTACACCTTCGGTTCG	CASSWTGLGGYTF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	7	0	5	22	-1	43	35	48	TCRBV02,TCRBV12													CASSWTGLGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCCCCCGGGGGCACGGCGGCGAGCAGTACTTCGGGCCG	CASSPRGHGGEQYF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	6	0	6	4	7	18	30	40	34	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRGHGGEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCATATCCACAGATACGCAGTATTTTGGCCCA	CASSISTDTQYF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	9	2	0	2	24	-1	39	37	41	TCRBV09,TCRBV21					01,02								CASSISTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCAACCCCTCCTACGAGCAGTACTTCGGGCCG	CSARSNPSYEQYF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	3	7	0	4	2	26	38	44	42	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSNPSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTAAAGATTTGGTGCGGGGTAGGAATGAGCAGTTCTTCGGGCCA	CASSKDLVRGRNEQFF	In	VDJ	1	64	4.971684701970807E-4	6.598958601845646E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	7	11	4	22	34	51	45	55	TCRBV02,TCRBV12													CASSKDLVRGRNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACAGGACGGTTGGGTAACTATGGCTACACCTTCGGTTCG	CATSDTGRLGNYGYTF	In	VDJ	1	64	4.971684701970807E-4	6.598958601845646E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	4	1	1	9	24	38	44	39	53		TCRBV24-01,TCRBV24-or09_02												CATSDTGRLGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACTAGTTTCGAGCAGTACTTCGGGCCG	CASSQTSFEQYF	In	VDJ	1	65	5.049367275439101E-4	6.702067329999484E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	8	6	0	3	26	-1	46	40	49		TCRBV03-01,TCRBV03-02				01,02								CASSQTSFEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAGCCGGGACAGGGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	65	5.049367275439101E-4		43				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	1	2	18	35	45	36	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCGCCCGGGATTACAGATACGCAGTATTTTGGCCCA	CASSPGITDTQYF	In	VDJ	1	66	5.127049848907395E-4	6.805176058153323E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	3	3	5	2	26	35	45	40	47		TCRBV03-01,TCRBV03-02												CASSPGITDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTCGTCCCCTGGGGAGGGCCGCGTGGGGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	66	5.127049848907395E-4		56	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	8	11	12	23	35	53	46	65	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTTCCCGCCCAGCCCCAGCATTTTGGTGAT	CASSLVPAQPQHF	In	VDJ	1	67	5.204732422375689E-4	6.908284786307161E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	1	10	0	7	5	1	26	42	49	47	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVPAQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCACTAGCGGGAGTCAATGAGCAGTTCTTCGGGCCA	CSARSLAGVNEQFF	In	VDJ	1	68	5.282414995843982E-4	7.011393514460999E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	2	6	2	1	26	38	51	40	52		TCRBV20-01,TCRBV20-or09_02												CSARSLAGVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGAAAGGGGTCTAGCTGCGAGATACGCAGTATTTTGGCCCA	CSGKGV*LRDTQYF	Stop	VDJ	1	68	5.282414995843982E-4		42	TCRBV20						TCRBJ02	TCRBJ02-03	01	7	5	2	5	4	10	26	33	42	37	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSGKGV*LRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSWGTVNTEAFF	In	VDJ	1	68	5.282414995843982E-4	7.011393514460999E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	3	0	24	36	-1	39	46		TCRBV24-01,TCRBV24-or09_02												CASSWGTVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATCCCTACAGGGGGCGGGTATCGGGGAGCTGTTTTTTGGAGAA	CSASLQGAGIGELFF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	0	7	6	6	26	34	49	40	55		TCRBV20-01,TCRBV20-or09_02												CSASLQGAGIGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCCCACTGGACGGTCTGTGGGATGGCTACACCTTCGGTTCG	CSASPLDGLWDGYTF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	1	7	6	9	10	26	34	47	43	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPLDGLWDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTAGCGGGAGGGTTCAATGAGCAGTTCTTCGGGCCA	CSLAGGFNEQFF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	5	0	6	1	2	26	32	44	33	46		TCRBV20-01,TCRBV20-or09_02												CSLAGGFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAGGAGCGCTACGAGCAGTACTTCGGGCCG	CASSEERYEQYF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	6	3	5	0	23	34	-1	39	43	TCRBV02,TCRBV09					01,02								CASSEERYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCAACAGGGGAGGTGAGCAGTTCTTCGGGCCA	CASSPNRGGEQFF	In	VDJ	1	71	5.515462716248864E-4	7.320719698922514E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	9	5	3	22	33	45	38	48		TCRBV12-03,TCRBV12-04												CASSPNRGGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGTGAGGGACGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQVVRDGGNTEAFF	In	VDJ	1	72	5.593145289717158E-4	7.423828427076352E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	2	1	10	0	26	42	-1	52	58		TCRBV03-01,TCRBV03-02												CASSQVVRDGGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGAGAGGGCTTTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	72	5.593145289717158E-4		41	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	7	5	5	26	39	49	44	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCACCAAGGTCTCGGTAGCCCCAAATCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	73	5.670827863185451E-4		52	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	11	5	7	4	15	7	24	31	50	46	57	TCRBV24,TCRBV28					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCGACTAGCGGTCCAGATACGCAGTATTTTGGCCCA	CASSSTSGPDTQYF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	5	4	1	2	19	32	42	33	44	TCRBV07,TCRBV11					01,02								CASSSTSGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGACTTAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSDLGGNQPQHF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	2	2	5	0	18	30	-1	35	40	TCRBV07,TCRBV11													CASSDLGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTAACTTGGGGGGCCCTCAATGAAAAACTGTTTTTTGGCAGT	CASSLTWGALNEKLFF	In	VDJ	1	74	5.748510436653745E-4	7.630045883384028E-4	48	TCRBV12						TCRBJ01	TCRBJ01-04	01	5	6	0	5	8	4	26	38	52	46	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTWGALNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCCGGGGCGGACGCGTATAGGGGAGCTGTTTTTTGGAGAA	CASSSPGRTRIGELFF	In	VDJ	1	74	5.748510436653745E-4	7.630045883384028E-4	48	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	7	0	8	5	11	24	36	46	41	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGRTRIGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCCCTACTAGCGGACAAGAGACCTAGTACTTCGGGCCA	CASSPTSGQET*YF	Stop	VDJ	1	75	5.826193010122039E-4		42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	5	12	4	11	22	33	45	37	56	TCRBV02,TCRBV12					01,02								CASSPTSGQET*YF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTCCTTCCAGACTGCAGCTCGGCTACACCTTCGGTTCG		Out	VDJ	1	75	5.826193010122039E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	10	8	9	7	23	35	48	44	55	TCRBV09,TCRBV21					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCAGGACAGTGAGATATGGCTACACCTTCGGTTCG	CAISRTVRYGYTF	In	VDJ	1	76	5.903875583590333E-4	7.836263339691705E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	5	2	5	23	34	42	36	47	TCRBV06,TCRBV10													CAISRTVRYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGTACAAGGGACTAGCACCAATGAGCAGTTCTTCGGGCCA	CASRVQGTSTNEQFF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	7	6	7	2	26	37	53	44	55		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASRVQGTSTNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGGGGGCGCATTCGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	77	5.981558157058627E-4		44	TCRBV24						TCRBJ02	TCRBJ02-07	01	5	6	0	4	1	9	24	37	44	38	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTTTCGCTCCCTATACGCAGTATTTTGGCCCA	CASSLAFAPYTQYF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	42							TCRBJ02	TCRBJ02-03	01	0	10	0	7	4	5	18	35	41	39	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAFAPYTQYF+X+TCRBJ02-03			TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCGGGACTGACTCACTATGGCTACACCTTCGGTTCG	CASRPGLTHYGYTF	In	VDJ	1	78	6.059240730526921E-4	8.042480795999381E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	0	10	3	3	5	24	35	44	38	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASRPGLTHYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCCACGAAGTCGGACTGAACAGGGCCCAACACTATGGCTACACCTTCGGTTCG	CARSHEVGLNRAQHYGYTF	In	VDJ	1	79	6.136923303995214E-4	8.145589524153219E-4	57				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	3	16	6	18	30	52	46	58	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												CARSHEVGLNRAQHYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGTGGACAGGCGATCAAAGCTTTCTTTGGACAA	CASSGGQAIKAFF	In	VDJ	1	79	6.136923303995214E-4	8.145589524153219E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	9	4	6	23	34	45	38	51	TCRBV02,TCRBV09													CASSGGQAIKAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGGTTTGGGAAATGAACACTGAAGCTTTCTTTGGACAA	CSARDRVWEMNTEAFF	In	VDJ	1	81	6.292288450931802E-4	8.351806980460896E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	8	0	8	2	26	40	52	48	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRVWEMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCTCATCGCGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	82	6.369971024400096E-4		41	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	2	4	6	0	24	36	-1	42	49	TCRBV24,TCRBV27													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCATACCAACAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIPTSTGELFF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	6	4	6	2	18	30	39	36	41	TCRBV07,TCRBV11													CASSIPTSTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTTGACACCTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLDTYSYNEQFF	In	VDJ	1	84	6.525336171336684E-4	8.661133164922411E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	6	0	6	4	24	36	46	42	50		TCRBV24-01,TCRBV24-or09_02												CASSLLDTYSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACACTTAGGGGGCGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	84	6.525336171336684E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	0	3	6	1	18	28	41	34	42	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCCGGGACAGGGGTAGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	85	6.603018744804977E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	2	5	3	5	26	40	53	43	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCATGGGATAGAGACGGGGGAGAAAAAGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	85	6.603018744804977E-4		44	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	8	2	8	11	9	26	30	47	41	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCACCACCGCGGACAGGGACCCATGAGCAGTTCTTCGGGCCA	CASSPPPRTGTHEQFF	In	VDJ	1	85	6.603018744804977E-4	8.764241893076249E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	3	8	10	4	24	36	54	46	58		TCRBV24-01,TCRBV24-or09_02												CASSPPPRTGTHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTTTTATCGGGGTAGGGACTGAAGCTTTCTTTGGACAA	CASSPFIGVGTEAFF	In	VDJ	1	86	6.680701318273271E-4	8.867350621230087E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	5	9	5	26	37	51	46	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPFIGVGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGACTGGGGAGATACGCAGTATTTTGGCCCA	CATSDDWGDTQYF	In	VDJ	1	88	6.83606646520986E-4	9.073568077537763E-4	39	TCRBV24						TCRBJ02	TCRBJ02-03	01	4	6	2	5	5	0	24	38	-1	43	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDDWGDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSLIAGGADTQYF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	5	0	4	1	1	26	41	53	42	54		TCRBV12-03,TCRBV12-04												CASSLIAGGADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAAAGGGTACTATGGCTACACCTTCGGTTCG	CASSHKGYYGYTF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	5	3	3	3	1	26	40	47	43	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHKGYYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTAAAACAGGGTCAAAGAACACTGAAGCTTTCTTTGGACAA	CASSKTGSKNTEAFF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	4	5	26	37	47	41	52		TCRBV03-01,TCRBV03-02												CASSKTGSKNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGACAGAAACACTGAAGCTTTCTTTGGACAA	CSARGDRNTEAFF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	2	2	1	26	39	46	41	47		TCRBV20-01,TCRBV20-or09_02												CSARGDRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCGGAGGCCAGGCAATCAGCCCCAGCATTTTGGTGAT	CSAGRRPGNQPQHF	In	VDJ	1	90	6.991431612146448E-4	9.27978553384544E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	1	2	4	4	26	35	44	39	48		TCRBV20-01,TCRBV20-or09_02												CSAGRRPGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCCCACAGAGTATATCTCTGGGGCTAACGTCCTGACTTTCGGGGCC	CASSPTEYISGANVLTF	In	VDJ	1	90	6.991431612146448E-4	9.27978553384544E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	7	0	10	17	1	23	36	58	53	59	TCRBV04,TCRBV23													CASSPTEYISGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCCAGCTCTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSAQLSTGELFF	In	VDJ	1	90	6.991431612146448E-4	9.27978553384544E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	3	4	5	4	2	5	23	36	41	38	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAQLSTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTCAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLAQLNTEAFF	In	VDJ	1	91	7.069114185614741E-4	9.382894261999278E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	0	1	1	18	35	39	36	40	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAQLNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCGGACAGGCGCTTAGTGGAAACACCATATATTTTGGAGAG	CSARSGQALSGNTIYF	In	VDJ	1	92	7.146796759083035E-4	9.486002990153116E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	4	3	3	7	26	38	48	41	55		TCRBV20-01,TCRBV20-or09_02												CSARSGQALSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCRGCCRTGTATSKCTGTGCTAGCAGCGCTAGTTCCTTGCCCCCGAATGAGCAGTTCTTCGGGCCA	CASSASSLPPNEQFF	In	VDJ	1	92	7.146796759083035E-4	9.486002990153116E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	8	7	1	13	19	31	36	32	49	TCRBV07,TCRBV11					01,02								CASSASSLPPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCGGCCRTGTATSKCTGTGCCAGCAGCCGTATTGTAGCGCCAGACGACCGAGCGGGCGTTACTCCCTACGAGCAGTACTTCGGGCCG	CASSRIVAPDDRAGVTPYEQYF	In	VDJ	1	92	7.146796759083035E-4	9.486002990153116E-4	66	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	4	2	23	8	15	27	56	50	64	TCRBV07,TCRBV11					01,02								CASSRIVAPDDRAGVTPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGAGGACTAGCGGGAGAGACTAGAAGCGAGCAGTACTTCGGGCCG	CATSDRGLAGETRSEQYF	In	VDJ	1	95	7.379844479487917E-4	9.795329174614631E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	2	6	4	10	24	38	55	42	65		TCRBV24-01,TCRBV24-or09_02												CATSDRGLAGETRSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTTCGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	96	7.457527052956211E-4		35	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	2	8	4	4	0	26	40	-1	44	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTACAGGGGAAACTCTGGAAACACCATATATTTTGGAGAG	CASSYRGNSGNTIYF	In	VDJ	1	96	7.457527052956211E-4	9.89843790276847E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	2	0	0	3	18	-1	38	31	41	TCRBV07,TCRBV11													CASSYRGNSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGGGACTAGCGGTGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	97	7.535209626424504E-4		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	4	4	6	26	34	49	38	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGATCGACGGGCCGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	97	7.535209626424504E-4		41	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	8	0	4	7	3	24	35	46	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCGGGACGGCAACCTACGAGCAGTACTTCGGGCCG	CATSDTGTATYEQYF	In	VDJ	1	98	7.612892199892798E-4	0.0010104655359076146	45	TCRBV24						TCRBJ02	TCRBJ02-07	01	3	0	7	2	3	5	24	39	47	42	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDTGTATYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCCCTCAGGGGGCGAAGAACACTGAAGCTTTCTTTGGACAA	CASTPQGAKNTEAFF	In	VDJ	1	98	7.612892199892798E-4	0.0010104655359076146	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	0	1	5	3	23	33	46	38	49	TCRBV02,TCRBV09													CASTPQGAKNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCGTACTAGCGGGAGGGAGCGAGCAGTACTTCGGGCCG	CASSVLAGGSEQYF	In	VDJ	1	99	7.690574773361092E-4	0.0010207764087229983	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	0	6	3	2	23	34	50	37	52	TCRBV24,TCRBV27													CASSVLAGGSEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGAACAGAGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	100	7.768257346829386E-4		38	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	3	5	5	6	3	26	34	44	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTACTAGCGGAGCAATACAATGAGCAGTTCTTCGGGCCA	CASSLLAEQYNEQFF	In	VDJ	1	101	7.84593992029768E-4	0.0010413981543537661	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	4	2	5	24	36	46	38	51	TCRBV06,TCRBV10					01,02								CASSLLAEQYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAACAGGGGCATAGGGGCTTTCTTTGGACAA	CASSQNRGIGAFF	In	VDJ	1	102	7.923622493765973E-4	0.0010517090271691498	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	11	1	7	26	41	49	42	56		TCRBV03-01,TCRBV03-02												CASSQNRGIGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGCCGACTAGCGAGACTCACCCTCTTACTTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	103	8.001305067234267E-4		64				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	6	4	5	19	17	31	44	36	63	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTCAAGGGTACTCTGGAAACACCATATATTTTGGAGAG	CASSVQGYSGNTIYF	In	VDJ	1	104	8.078987640702561E-4	0.0010723307727999176	45	unresolved						TCRBJ01	TCRBJ01-03	01	5	5	3	0	5	2	24	36	45	41	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVQGYSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGAACCTCCGGGACCCTTACATACGAGCAGTACTTCGGGCCG	CASSRTSGTLTYEQYF	In	VDJ	1	105	8.156670214170855E-4	0.0010826416456153013	48	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	0	7	4	10	7	24	35	50	45	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTSGTLTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAAGGGGACTAGCGGGAGGGAAGAGACCCAGTACTTCGGGCCA	CASSKGTSGREETQYF	In	VDJ	1	105	8.156670214170855E-4	0.0010826416456153013	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	0	3	3	0	18	30	-1	33	49	TCRBV07,TCRBV11													CASSKGTSGREETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGTGGGACTAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLVGLAYNEQFF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	8	2	3	0	26	40	-1	43	51		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLVGLAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATGAAAACCCGGGACAGTATCAATGAGCAGTTCTTCGGGCCA	CSAMKTRDSINEQFF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	6	11	3	26	34	52	45	55		TCRBV20-01,TCRBV20-or09_02												CSAMKTRDSINEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACACGGAGCGGGAGGGGGTACGCAGTATTTTGGCCCA	CSARVHGAGGGTQYF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	0	8	7	2	26	39	56	46	58		TCRBV20-01,TCRBV20-or09_02												CSARVHGAGGGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGGACTAGCGGGTCTAATCCGGGGAGCTGTTTTTTGGAGAA	CATSDWD*RV*SGELFF	Stop	VDJ	1	107	8.312035361107443E-4		51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	4	6	0	6	24	-1	52	40	58		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDWD*RV*SGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCRTGTATSKCTGTGCCACCAGCCAGGCTGGGGGGCCTTTGTACGAGCAGTACTTCGGGCCG	CATSQAGGPLYEQYF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	6	0	4	7	5	18	30	43	37	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSQAGGPLYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGGTCCTAACTATGGCTACACCTTCGGTTCG	CSARQGPNYGYTF	In	VDJ	1	108	8.389717934575736E-4	0.0011135742640614528	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	0	0	2	26	-1	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSARQGPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTGCAGGATCCGCATGGCTACACCTTCGGTTCG		Out	VDJ	1	110	8.545083081512324E-4		44	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	6	4	6	26	42	50	46	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCAGTCCCGCGGATGGCTACACCTTCGGTTCG	CSATSPADGYTF	In	VDJ	1	110	8.545083081512324E-4	0.0011341960096922204	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	5	6	10	0	26	34	-1	44	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSATSPADGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACATCGGGGTATGGCTACACCTTCGGTTCG	CSARTSGYGYTF	In	VDJ	1	110	8.545083081512324E-4	0.0011341960096922204	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	3	5	4	0	26	38	-1	42	47		TCRBV20-01,TCRBV20-or09_02												CSARTSGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGAGCGGGAGTTAGTAATACGCAGTATTTTGGCCCA	CSAPGAGVSNTQYF	In	VDJ	1	110	8.545083081512324E-4	0.0011341960096922204	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	2	7	5	6	26	35	48	40	54		TCRBV20-01,TCRBV20-or09_02												CSAPGAGVSNTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGAGGGGCGCGGGGCTACACCTTCGGTTCG		Out	VDJ	1	110	8.545083081512324E-4		37	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	5	5	2	8	3	5	23	35	43	38	48	TCRBV06,TCRBV10			TCRBD01,TCRBD02										X+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTCGTTGATGGGTCACTCGGGTACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVVDGSLGYANTGELFF	In	VDJ	1	111	8.622765654980618E-4	0.0011445068825076043	60	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	4	0	16	4	21	34	54	50	58		TCRBV24-01,TCRBV24-or09_02				01,02								CASSVVDGSLGYANTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLSGEETQYF	In	VDJ	1	111	8.622765654980618E-4	0.0011445068825076043	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	2	3	4	0	24	36	-1	40	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSGEETQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCATTAGAAGAACTAGCGGGGCGGGGAATGAGCAGTTCTTCGGGCCA	CSAPIRRTSGAGNEQFF	In	VDJ	1	112	8.700448228448912E-4	0.001154817755322988	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	3	7	12	5	26	35	57	47	62		TCRBV20-01,TCRBV20-or09_02												CSAPIRRTSGAGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAGTCGGAGGAAACACTGAAGCTTTCTTTGGACAA	CASSLVGGNTEAFF	In	VDJ	1	112	8.700448228448912E-4	0.001154817755322988	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	2	2	1	18	34	41	36	42	TCRBV03,TCRBV11													CASSLVGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCTACGACAGGGGCAGATACGCAGTATTTTGGCCCA	CATSDPTTGADTQYF	In	VDJ	1	115	8.933495948853793E-4	0.0011857503737691395	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	4	6	0	24	38	-1	44	52		TCRBV24-01,TCRBV24-or09_02												CATSDPTTGADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAAGAGACGGTGAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	115	8.933495948853793E-4		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	2	6	5	16	5	18	26	46	42	51	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTACGACTCACCACAGATACGCAGTATTTTGGCCCA	CSARLRLTTDTQYF	In	VDJ	1	116	9.011178522322087E-4	0.0011960612465845234	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	2	4	3	26	38	46	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLRLTTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACTCCAGGGTAACTATGGCTACACCTTCGGTTCG	CASSQLQGNYGYTF	In	VDJ	1	117	9.088861095790381E-4	0.001206372119399907	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	1	3	0	23	38	-1	41	46	TCRBV01,TCRBV04													CASSQLQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCTACAGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLYRGMNTEAFF	In	VDJ	1	117	9.088861095790381E-4	0.001206372119399907	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	0	3	1	23	36	47	39	48	TCRBV01,TCRBV04													CASSLYRGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGATGGGGGGGCCGACTATGGCTACACCTTCGGTTCG	CSASDGGADYGYTF	In	VDJ	1	121	9.399591389663557E-4	0.0012476156106614425	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	9	0	3	4	3	26	37	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSASDGGADYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTCAAAGATGCCCTCGGGACACTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSALKDALGTLYSNQPQHF	In	VDJ	1	122	9.477273963131851E-4	0.0012579264834768262	57	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	6	0	16	5	24	32	54	48	59		TCRBV20-01,TCRBV20-or09_02												CSALKDALGTLYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGATCAGGGGGCCGGCTGCCCCAGCATTTTGGTGAT	CSARGSGGRLPQHF	In	VDJ	1	123	9.554956536600145E-4	0.0012682373562922101	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	9	5	5	26	37	50	42	55		TCRBV20-01,TCRBV20-or09_02												CSARGSGGRLPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGGACAGGCCCTACGAGCAGTACTTCGGGCCG	CSAADRPYEQYF	In	VDJ	1	123	9.554956536600145E-4	0.0012682373562922101	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	2	2	1	26	35	44	37	45		TCRBV20-01,TCRBV20-or09_02												CSAADRPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCTCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSALSYNEQFF	In	VDJ	1	126	9.788004257005026E-4	0.0012991699747383616	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	10	0	2	0	24	37	-1	39	41		TCRBV24-01,TCRBV24-or09_02				01,02								CATSALSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCTCCCGGGCTGGGACGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSPSRAGTAQETQYF	In	VDJ	1	127	9.86568683047332E-4	0.0013094808475537455	51	TCRBV12						TCRBJ02	TCRBJ02-05	01	5	0	7	1	12	3	22	34	51	46	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSRAGTAQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGAGCAGGGGCGCCTCACTAATGAAAAACTGTTTTTTGGCAGT	CATSDLEQGRLTNEKLFF	In	VDJ	1	127	9.86568683047332E-4	0.0013094808475537455	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	2	4	6	24	41	51	45	57		TCRBV24-01,TCRBV24-or09_02												CATSDLEQGRLTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGTAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLVGGNTEAFF	In	VDJ	1	128	9.943369403941614E-4	0.0013197917203691292	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	1	1	3	0	18	32	-1	35	41	TCRBV07,TCRBV11													CASSLVGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGAAAACAGGAGCAGGGTCAGCCCCAGCATTTTGGTGAT	CASSPRKQEQGQPQHF	In	VDJ	1	132	0.001025409969781479	0.0013610352116306646	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	6	7	7	26	39	51	46	58		TCRBV03-01,TCRBV03-02												CASSPRKQEQGQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGGGACGGGAGTCTACGAGCAGTACTTCGGGCCG	CSARAGTGVYEQYF	In	VDJ	1	137	0.0010642512565156258	0.0014125895757075837	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	3	6	1	26	39	51	45	52		TCRBV20-01,TCRBV20-or09_02												CSARAGTGVYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCAGCAGGATTTTAATACGGCTACACCTTCGGTTCG		Out	VDJ	1	138	0.0010720195138624552		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	8	6	10	26	37	47	43	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAATTGATACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	140	0.001087556028556114		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	6	5	9	5	26	38	50	47	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGCCAGGGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	141	0.0010953242859029434		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	1	2	4	0	24	40	-1	44	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCAGGGACAGGGAATACGAGCAGTACTTCGGGCCG	CSARPRDREYEQYF	In	VDJ	1	142	0.0011030925432497728	0.0014641439397845028	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	4	4	2	26	38	51	42	53		TCRBV20-01,TCRBV20-or09_02												CSARPRDREYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTACGAGCAGTACTTCGGGCCG	CASSQDYEQYF	In	VJ	1	143	0.0011108608005966022	0.0014744548125998865	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	0	0	3	0	0	26	-1	-1	-1	43		TCRBV03-01,TCRBV03-02												CASSQDYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GTATCTCTGTGCCAGCAGCTTAGGTCGGTTAACTAGCGGGCTACCCAACCGGGGGGGCTACTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	143	0.0011108608005966022		74				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	4	2	8	22	7	23	40	31	62	TCRBV07,TCRBV11	TCRBV07-02,TCRBV07-04,TCRBV07-08,TCRBV07-09,TCRBV11-01,TCRBV11-02,TCRBV11-03				01,02								X+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCGAGCTCCTTTTTGGCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	144	0.0011186290579434316		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	7	5	1	15	1	26	31	50	46	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCGCAAGCAAGTGACTACGAGCAGTACTTCGGGCCG	CASSPQASDYEQYF	In	VDJ	1	146	0.0011341655726370902	0.001505387431046038	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	7	3	4	6	23	36	43	40	49	TCRBV01,TCRBV04					01,02								CASSPQASDYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGACTAGCGGGAGTCGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CATGTSGSRSTGELFF	In	VDJ	1	146	0.0011341655726370902	0.001505387431046038	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	9	0	2	4	0	6	24	-1	47	33	53		TCRBV24-01,TCRBV24-or09_02												CATGTSGSRSTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGCCTCAGGGACTAGCGCCACAGATACGCAGTATTTTGGCCCA	CASASGTSATDTQYF	In	VDJ	1	146	0.0011341655726370902	0.001505387431046038	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	6	2	6	1	23	32	48	38	49	TCRBV06,TCRBV10					01,02								CASASGTSATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGGTTTCTATGGCTACACCTTCGGTTCG	CATSDRGFYGYTF	In	VDJ	1	148	0.001149702087330749	0.0015260091766768056	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	4	1	3	24	38	44	39	47		TCRBV24-01,TCRBV24-or09_02												CATSDRGFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTGTCGGGAGGGATACTCCCGGGACTGATCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	150	0.0011652386020244078		53	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	8	0	4	4	19	24	31	43	35	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCATGTCGCTGGGGACTACGAGCAGTATTTCGGGCCG	CASSHVAGDYEQYF	In	VDJ	1	151	0.0011730068593712372	0.0015569417951229571	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	9	16	8	10	23	37	52	45	62	TCRBV01,TCRBV04					01,02								CASSHVAGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGACCGGGACTAGCGGGAGATTCGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	151	0.0011730068593712372		56	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	2	5	5	24	36	55	41	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATCAACTACGAGCAGTACTTCGGGCCG	CSARDINYEQYF	In	VDJ	1	153	0.001188543374064896	0.0015775635407537247	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	6	3	3	1	26	40	45	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDINYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGACACTCGGGAGGACTGAAGCTTTCTTTGGACAA	CSAETLGRTEAFF	In	VDJ	1	153	0.001188543374064896	0.0015775635407537247	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	1	5	8	0	26	35	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSAETLGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGACAACATGAACACTGAAGCTTTCTTTGGACAA	CSASRDNMNTEAFF	In	VDJ	1	157	0.0012196164034522137	0.0016188070320152601	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	0	2	3	26	37	45	39	48		TCRBV20-01,TCRBV20-or09_02												CSASRDNMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGGGGGAGACTATGGCTACACCTTCGGTTCG	CASRGGDYGYTF	In	VDJ	1	157	0.0012196164034522137	0.0016188070320152601	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	5	1	3	0	2	24	-1	41	35	43		TCRBV24-01,TCRBV24-or09_02												CASRGGDYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCAGCAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSFSRAGELFF	In	VDJ	1	157	0.0012196164034522137	0.0016188070320152601	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	6	5	0	24	36	-1	41	46		TCRBV24-01,TCRBV24-or09_02												CASSFSRAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAGGGCTAGCGGGAGAAGATTCTACGAGCAGTACTTCGGGCCG	CASSQERASGRRFYEQYF	In	VDJ	1	159	0.0012351529181458723	0.0016394287776460277	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	2	3	5	6	26	43	58	48	64		TCRBV03-01,TCRBV03-02												CASSQERASGRRFYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCCCAGGGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CSAIPRGGNQPQHF	In	VDJ	1	162	0.0012584576901863605	0.0016703613960921792	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	2	4	2	26	36	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSAIPRGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCGACAGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSLRQSYNEQFF	In	VDJ	1	163	0.0012662259475331899	0.0016806722689075631	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	3	3	2	26	39	47	42	49		TCRBV03-01,TCRBV03-02												CASSLRQSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTTTTAACTCTACAGGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLLTLQGGTGELFF	In	VDJ	1	168	0.001305067234267337	0.0017322266329844822	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	1	5	11	2	24	36	55	47	57		TCRBV24-01,TCRBV24-or09_02												CASSLLTLQGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACTTGCCGCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	171	0.001328372006307825		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	7	5	3	6	0	26	36	-1	42	46		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATTGGCCCCGGGACTAGCACCAATACGAGCAGTACTTCGGGCCG	CSARDWPRD*HQYEQYF	Stop	VDJ	1	175	0.0013594450356951425		51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	7	4	11	5	26	37	57	48	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDWPRD*HQYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTGACTGTGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	175	0.0013594450356951425		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	10	4	4	4	24	36	44	40	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCCCCCGGGACTCTGGGTAGGGATGAGCAGTTCTTCGGGCCA	CASSSAPGTLGRDEQFF	In	VDJ	1	181	0.0014060545797761187	0.001866267979584472	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	8	4	10	18	35	45	39	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSSAPGTLGRDEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAGTTCCCGGGATTTGAGACCCAGTACTTCGGGCCA	CASSEFPGFETQYF	In	VDJ	1	185	0.0014371276091634363	0.0019075114708460071	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	3	5	7	3	22	34	46	41	49	TCRBV02,TCRBV12													CASSEFPGFETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCGAGGCGGCGGGACGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSRGGGTGGTEAFF	In	VDJ	1	186	0.0014448958665102657	0.001917822343661391	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	4	13	0	18	30	-1	43	50	TCRBV05,TCRBV11													CASSRGGGTGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAATGGCGAGTTTACAATGAGCAGTTCTTCGGGCCA	CSAKWRVYNEQFF	In	VDJ	1	187	0.0014526641238570951	0.0019281332164767747	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	9	0	4	5	5	26	34	42	39	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKWRVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAACAGCCAAGACGGGAATAGATACAATGAGCAGTTCTTCGGGCCA	CANSQDGNRYNEQFF	In	VDJ	1	189	0.001468200638550754	0.0019487549621075423	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	3	4	0	5	23	-1	45	40	50	TCRBV04,TCRBV23													CANSQDGNRYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAGTAGATTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	190	0.0014759688958975834		43	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	3	11	26	38	44	41	55		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGGCCTTTTCGAGCAGTTCTTCGGGCCA	CASSQDWGLFEQFF	In	VDJ	1	194	0.0015070419252849008	0.0020003093261844614	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	10	2	6	26	43	50	45	56		TCRBV03-01,TCRBV03-02												CASSQDWGLFEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATCGGGCTACAGATACGCAGTATTTTGGCCCA	CSARNRATDTQYF	In	VDJ	1	194	0.0015070419252849008	0.0020003093261844614	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	8	0	3	4	1	26	38	46	42	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARNRATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGAACGATACGGGACTAGCGTCTTGACCGGGGAGCTGTTTTTTGGAGAA	CASSQERYGTSVLTGELFF	In	VDJ	1	195	0.0015148101826317302	0.0020106201989998455	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	6	5	10	5	23	37	57	47	62	TCRBV01,TCRBV04					01,02								CASSQERYGTSVLTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGAGGAACTAGCGGGAGTACAGAATGAGCAGTTCTTCGGGCCA	CSARPEELAGVQNEQFF	In	VDJ	1	195	0.0015148101826317302	0.0020106201989998455	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	3	2	7	8	5	26	38	57	46	62		TCRBV20-01,TCRBV20-or09_02												CSARPEELAGVQNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAGCTGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSQLGSTEAFF	In	VDJ	1	196	0.0015225784399785596	0.0020209310718152292	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	2	4	6	0	26	38	-1	44	49		TCRBV12-03,TCRBV12-04												CASSQLGSTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTCGGTGCATACAAAGGGGAGACCCAGTACTTCGGGCCA	CASSVGAYKGETQYF	In	VDJ	1	198	0.0015381149546722184	0.0020415528174459966	45	unresolved						TCRBJ02	TCRBJ02-05	01	4	5	3	5	13	0	23	36	-1	49	53	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGAYKGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTCACCTCGGGAGCGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSSPRERITGELFF	In	VDJ	1	201	0.0015614197267127066	0.002072485435892148	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	8	2	4	5	5	22	35	46	40	51	TCRBV12,TCRBV21													CASSSPRERITGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACAGACAGGGCGGAGCGGTGACCTACAATGAGCAGTTCTTCGGGCCA	CASNRQGGAVTYNEQFF	In	VDJ	1	204	0.0015847244987531946	0.0021034180543382996	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	3	2	3	11	26	36	46	39	57		TCRBV03-01,TCRBV03-02												CASNRQGGAVTYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCCTAGGGACAGGGAAGGGCTACGAGCAGTACTTCGGGCCG	CSASPLGTGKGYEQYF	In	VDJ	1	208	0.0016157975281405122	0.0021446615455998352	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	3	7	5	26	37	53	44	58		TCRBV20-01,TCRBV20-or09_02												CSASPLGTGKGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACTCCGGGACTAGCCGTCCAGAGCAGTTCTTCGGGCCA	CSARNSGTSRPEQFF	In	VDJ	1	212	0.0016468705575278298	0.0021859050368613704	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	7	10	6	6	26	38	53	44	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARNSGTSRPEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAGCGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	213	0.0016546388148746592		41	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	5	0	2	1	26	39	46	41	47		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAAATCCCGCCAGGGGCAGACAAAATGAAAAACTGTTTTTTGGCAGT	CASSLNPARGRQNEKLFF	In	VDJ	1	213	0.0016546388148746592	0.002196215909676754	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	5	8	7	18	33	47	41	54	TCRBV07,TCRBV11													CASSLNPARGRQNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTTCTGGGGGGCGAGGTGAAAAACTGTTTTTTGGCAGT	CASSPSGGRGEKLFF	In	VDJ	1	225	0.0017478579030366119	0.00231994638346136	45	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	6	0	7	7	4	24	36	49	43	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSGGRGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGACACCGGCTCTGGAAACACCATATATTTTGGAGAG	CSAQDTGSGNTIYF	In	VDJ	1	226	0.0017556261603834413	0.002330257256276744	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	0	2	4	26	35	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSAQDTGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGTTGGCGGGAGGTAACCTCTACGAGCAGTACTTCGGGCCG	CSAKLAGGNLYEQYF	In	VDJ	1	231	0.001794467447117588	0.002381811620353663	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	7	1	3	5	6	26	36	49	41	55		TCRBV20-01,TCRBV20-or09_02												CSAKLAGGNLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGTAGACAGGGCGTGACGAGCAGTACTTCGGGCCG	CATK*TGRDEQYF	Stop	VDJ	1	231	0.001794467447117588		39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	3	5	4	4	24	34	45	38	49		TCRBV24-01,TCRBV24-or09_02												CATK*TGRDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCTTACCCTTGACAGAGCAAGAGACCCAGTACTTCGGGCCA	CASSFLPLTEQETQYF	In	VDJ	1	233	0.0018100039618112469	0.0024024333659844305	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	2	9	2	18	32	46	41	48	TCRBV05,TCRBV11													CASSFLPLTEQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAATTGTTTGTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSELFVSYNEQFF	In	VJ	1	235	0.0018255404765049057	0.0024230551116151983	45	unresolved						TCRBJ02	TCRBJ02-01	01	2	0	0	1	0	9	23	-1	38	-1	47	TCRBV02,TCRBV09													CASSELFVSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCAGATATCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	237	0.0018410769911985645		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCACTGTTCTGTACCACGAGCAGTACTTCGGGCCG	CASSRTVLYHEQYF	In	VDJ	1	243	0.0018876865352795407	0.0025055420941382687	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	10	5	2	10	26	39	44	41	54		TCRBV03-01,TCRBV03-02				01,02								CASSRTVLYHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGCTAGGGCGCCTGGACACTGAAGCTTTCTTTGGACAA	CSASLLGRLDTEAFF	In	VDJ	1	243	0.0018876865352795407	0.0025055420941382687	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	5	3	3	6	7	26	37	47	43	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLLGRLDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGCGGGGAAAGAAAGTGTTGACTGAAGCTTTCTTTGGACAA	CSARGRGKKVLTEAFF	In	VDJ	2	244	0.0018954547926263701	0.0025158529669536524	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	3	5	1	13	26	39	46	40	59		TCRBV20-01,TCRBV20-or09_02												CSARGRGKKVLTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATAGGCACAGATACGCAGTATTTTGGCCCA	CASSLIGTDTQYF	In	VDJ	2	244	0.0018954547926263701	0.0025158529669536524	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	8	1	4	0	24	36	-1	40	43		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLIGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCTCCGGAGCACGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTLRSTSYNEQFF	In	VDJ	2	247	0.0019187595646668583	0.002546785585399804	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	1	7	4	26	38	49	45	53		TCRBV03-01,TCRBV03-02												CASSTLRSTSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TTTCTGTGCCAGCAGCCAAGACATTATTGTAACACGGACCGAGCATGCTGGACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	248	0.0019265278220136877		67	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	1	7	3	14	12	4	21	39	35	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTAAGGACAGGCATCCTATGGCTACACCTTCGGTTCG	CATSD*GQASYGYTF	Stop	VDJ	2	249	0.0019342960793605171		45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	4	4	2	4	24	40	49	42	53		TCRBV24-01,TCRBV24-or09_02												CATSD*GQASYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGCAGGGAGCTTTTACAATGAGCAGTTCTTCGGGCCA	CSARAGSFYNEQFF	In	VDJ	2	250	0.0019420643367073465	0.0025777182038459554	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	4	3	4	5	6	26	34	44	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAGSFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGAAGGGGGCGGCAGTACTTCGGGCCG	CASSPPGRGRQYF	In	VDJ	2	251	0.0019498325940541757	0.0025880290766613395	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	0	9	8	1	26	39	54	47	55		TCRBV03-01,TCRBV03-02												CASSPPGRGRQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTCCCTCCCTGGTCGTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLLPPWSLAKNIQYF	In	VDJ	2	254	0.001973137366094664	0.002618961695107491	54	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	3	10	0	2	15	24	36	41	38	56		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLLPPWSLAKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCAGTGGGACACGACAAACTGAAGCTTTCTTTGGACAA	CARSFSGTRQTEAFF	In	VDJ	2	266	0.002066356454256617	0.0027426921688920966	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	5	4	6	18	32	42	36	48	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												CARSFSGTRQTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACAGGGACCCTACGAGCAGTACTTCGGGCCG	CASSRQGPYEQYF	In	VDJ	2	267	0.002074124711603446	0.0027530030417074807	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	2	0	2	26	-1	46	39	48		TCRBV03-01,TCRBV03-02												CASSRQGPYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGGAGGGCCCCGATATGAGCAGTTCTTCGGGCCA	CASSLAGGPRYEQFF	In	VDJ	2	269	0.002089661226297105	0.002773624787338248	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	8	0	7	18	-1	42	35	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGPRYEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGCCAACAGGGGAGCTGAAGCTTTCTTTGGACAA	CASSHANRGAEAFF	In	VDJ	2	280	0.002175112057112228	0.00288704438830747	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	6	5	2	26	40	52	45	54		TCRBV03-01,TCRBV03-02												CASSHANRGAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACACTGGACAGGGTGGTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDTGQGGYTGELFF	In	VDJ	2	280	0.002175112057112228	0.00288704438830747	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	3	4	5	23	40	52	44	57	TCRBV01,TCRBV04													CASSQDTGQGGYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAGTAGGGTCCCCCTACGAGCAGTACTTCGGGCCG	CASSLGVGSPYEQYF	In	VDJ	2	281	0.002182880314459057	0.002897355261122854	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	1	5	3	2	4	4	26	42	50	46	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGSPYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACACAGGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSQTQGKNTEAFF	In	VDJ	2	300	0.0023304772040488157	0.003093261844615147	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	1	3	2	26	40	50	43	52		TCRBV03-01,TCRBV03-02												CASSQTQGKNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTCTCGCCTGGCGGGACGGGGAGACCCAGTACTTCGGGCCA	CSARALAWRDGETQYF	In	VDJ	2	302	0.0023460137187424745	0.0031138835902459142	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	3	5	10	4	26	39	55	49	59		TCRBV20-01,TCRBV20-or09_02												CSARALAWRDGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCAGGACTAGCGGTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	305	0.0023693184907829625		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	5	3	6	2	26	35	51	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAAAGGTTGGGACGGCTTCTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	313	0.0024314645495575977		53	unresolved						TCRBJ02	TCRBJ02-02	01	3	0	7	4	8	7	23	37	50	45	57	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAATAAGTTTGGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQNKFGSSGANVLTF	In	VDJ	2	331	0.0025712931818005266	0.003412898901892045	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	9	2	0	9	0	26	41	-1	50	55		TCRBV03-01,TCRBV03-02												CASSQNKFGSSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01*02	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGCGGGGTTCTCCGGGGAGCTGTTTTTTGGAGAA	CATSDSAGFSGELFF	In	VDJ	2	338	0.002625670983228332	0.003485075011599732	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	3	6	2	4	24	40	48	42	52		TCRBV24-01,TCRBV24-or09_02												CATSDSAGFSGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCTAGAGAGGGCTCGAAACACTGAAGCTTTCTTTGGACAA	CASSPLERARNTEAFF	In	VDJ	2	347	0.002695585299349797	0.0035778728669381863	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	0	2	7	5	26	39	51	46	56		TCRBV03-01,TCRBV03-02												CASSPLERARNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAATTCTGTGACAGGGGAGTTGACAGATACGCAGTATTTTGGCCCA	CANSVTGELTDTQYF	In	VDJ	2	380	0.0029519377917951667	0.0039181316698458524	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	2	2	3	7	5	22	29	44	36	49		TCRBV12-03,TCRBV12-04												CANSVTGELTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGAAAGTGGAACCATAGATACGCAGTATTTTGGCCCA	CASSSESGTIDTQYF	In	VDJ	2	387	0.0030063155932229723	0.003990307779553539	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	1	8	5	9	5	24	36	48	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSESGTIDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTATCCTCGCGCGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	387	0.0030063155932229723		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	6	4	5	3	18	33	41	38	44	TCRBV05,TCRBV11					01,02								X+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACCAAGCGGGACAGCCTACGAGCAGTACTTCGGGCCG	CASSQGPSGTAYEQYF	In	VDJ	2	388	0.0030140838505698015	0.004000618652368923	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	0	5	2	8	0	26	42	-1	50	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGPSGTAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGAGGGACAGCCTACGAGCAGTACTTCGGGCCG	CASSQDRGTAYEQYF	In	VDJ	2	388	0.0030140838505698015	0.004000618652368923	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	2	4	0	23	40	-1	44	51	TCRBV01,TCRBV04													CASSQDRGTAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGGAGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLREESTDTQYF	In	VDJ	2	394	0.003060693394650778	0.004062483889261226	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	1	0	1	2	26	41	48	42	50		TCRBV12-03,TCRBV12-04												CASSLREESTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDSNQPQHF	In	VJ	3	427	0.0033170458870961476	0.004402742692168892	39	unresolved						TCRBJ01	TCRBJ01-05	01	0	0	0	1	0	1	23	-1	40	-1	41	TCRBV01,TCRBV04													CASSQDSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTTGGTGGCACCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	436	0.003386960203217612		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	9	0	0	7	3	26	40	50	47	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAACGCGCTTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	469	0.0036433126956629818		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	7	6	4	3	16	26	38	44	41	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGGACAGGGAAGTCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	479	0.003720995269131276		58	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	0	4	9	23	37	50	41	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACAGGACAGACAGGAGCTTTCTTTGGACAA	CASSLTGQTGAFF	In	VDJ	3	480	0.003728763526478105	0.0049492189513842344	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	10	3	5	26	41	50	44	55		TCRBV12-03,TCRBV12-04												CASSLTGQTGAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTTTTACTTGTACGCAGTATTTTGGCCCA		Out	VDJ	3	522	0.004055030335044939		40	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	10	8	5	2	26	43	51	48	53		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTACAGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CSASLQLAKNIQYF	In	VDJ	3	566	0.004396833658305432	0.005835954013507243	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	5	0	3	2	26	37	44	40	46		TCRBV20-01,TCRBV20-or09_02												CSASLQLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTACAGGGCGTAGCACAGATACGCAGTATTTTGGCCCA	CATSATGRSTDTQYF	In	VDJ	4	716	0.0055620722603298405	0.0073825849358148165	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	3	0	2	3	24	37	45	39	48		TCRBV24-01,TCRBV24-or09_02												CATSATGRSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGTGAGGGGAGAGCGATGAACACTGAAGCTTTCTTTGGACAA	CASSESEGRAMNTEAFF	In	VDJ	5	830	0.0064476535978683905	0.008558024436768572	51	TCRBV06						TCRBJ01	TCRBJ01-01	01	2	5	2	0	4	7	23	38	47	42	54		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESEGRAMNTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCTGGGAGGCGGAGGTCCTAATGAGCAGTTCTTCGGGCCA	CASSHLGGGGPNEQFF	In	VDJ	5	878	0.006820529950516201	0.009052946331906996	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	1	7	3	10	26	40	49	43	59		TCRBV03-01,TCRBV03-02												CASSHLGGGGPNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTGGGACAGTCCCACAGATACGCAGTATTTTGGCCCA	CASSFWDSPTDTQYF	In	VDJ	6	895	0.0069525903254123	0.00922823116976852	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	2	2	3	26	40	49	42	52		TCRBV12-03,TCRBV12-04												CASSFWDSPTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGGACAGCAACACTGAAGCTTTCTTTGGACAA	CASSLLDSNTEAFF	In	VDJ	6	917	0.007123491987042547	0.009455070371706965	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	2	5	1	24	36	47	41	48		TCRBV24-01,TCRBV24-or09_02												CASSLLDSNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGCCTATACCTGACGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSLYLTSSYEQYF	In	VDJ	6	930	0.007224479332551329	0.009589111718306955	48	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	2	7	0	11	3	24	36	50	47	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLYLTSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATGAAGGGGGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	7	1102	0.008560619596205982		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	1	5	2	26	43	54	48	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTCCAGGTTGGGACGAGCAGTACTTCGGGCCG	CASSLFPGWDEQYF	In	VDJ	7	1127	0.008754826029876718	0.011620353662937568	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	4	5	7	5	24	36	47	43	52		TCRBV24-01,TCRBV24-or09_02												CASSLFPGWDEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGACGCCGGCTCTGAGCAGTTCTTCGGGCCA	CASSLSDAGSEQFF	In	VDJ	8	1307	0.010153112352306008	0.013476310769706656	42							TCRBJ02	TCRBJ02-01	01	6	1	7	9	5	8	24	36	45	41	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSDAGSEQFF+X+TCRBJ02-01			TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGTCCCCACACGCGAACACTGAAGCTTTCTTTGGACAA	CASSQSPHANTEAFF	In	VDJ	14	2306	0.017913601441788565	0.023776872712275094	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	6	1	6	3	23	37	46	43	49	TCRBV01,TCRBV04													CASSQSPHANTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGTAGGGGCGGGATACAAGAGACCCAGTACTTCGGGCCA	CASSQGRGGIQETQYF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	3	2	8	2	23	37	51	45	53													Vb 7.1	CASSQGRGGIQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAGTAGGGGTGGAACAGATACGCAGTATTTTGGCCCA	CASSQSRGGTDTQYF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	3	3	4	23	38	46	41	50													Vb 7.1	CASSQSRGGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCAACAAGAAAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	98	7.612892199892798E-4		46	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	6	1	1	6	26	43	47	44	53			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTGTGGTCAAACAGGGCTCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	110	8.545083081512324E-4		59	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	3	3	0	8	4	22	38	52	46	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-06	TCRBV10-01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAACCGGGACAGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	122	9.477273963131851E-4		40	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	3	1	22	32	42	35	43														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTACAGCTGTGTAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	160	0.0012429211754927017		49	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	5	5	0	12	22	-1	39	35	51														X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGGCCGGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSRGAGGSTDTQYF	In	VDJ	1	50	3.884128673414693E-4	5.155436407691911E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	3	6	0	0	0	7	18	-1	38	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGAGGSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGCTCCAGGGCACTAGCGGGGGTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	53	4.1171763938195746E-4		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	0	11	3	18	30	52	41	55														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGGGAGGGGATGGACAATGAGCAGTTCTTCGGGCCA	CATSRDGEGMDNEQFF	In	VDJ	1	59	4.583271834629338E-4	6.083414961076455E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	0	5	2	5	18	35	44	37	49														CATSRDGEGMDNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGCAAGACTTCTCCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	75	5.826193010122039E-4		46	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	2	10	2	5	5	18	30	39	35	44						01,02								X+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD02-01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAACGTAGCGACCGGGACAGGGGGGTAGCTTTCTTTGGACAA	CATSKRSDRDRGVAFF	In	VDJ	1	140	0.001087556028556114	0.001443522194153735	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	1	10	12	2	18	31	54	43	56														CATSKRSDRDRGVAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATTTTGTTGGTAGCGGGAGTACATGAGCAGTTCTTCGGGCCA	CATSILLVAGVHEQFF	In	VDJ	1	140	0.001087556028556114	0.001443522194153735	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	2	8	9	3	18	31	49	40	52														CATSILLVAGVHEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCAGAACGGACAGTCGCAGGCCGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	163	0.0012662259475331899		61	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	5	3	7	11	18	35	48	42	59														X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACAGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CATSRQGSNQPQHF	In	VDJ	1	166	0.001289530719573678	0.0017116048873537144	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	0	0	0	18	-1	-1	33	38														CATSRQGSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACGGGTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSTGSGSTDTQYF	In	VDJ	4	579	0.0044978210038142145	0.005969995360107233	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	4	0	4	0	18	31	-1	35	42						01,02								CATSTGSGSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGGACGAACACTGAAGCTTTCTTTGGACAA	CATSREGTNTEAFF	In	VDJ	8	1294	0.010052125006797225	0.013342269423106666	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	0	7	1	1	0	18	35	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREGTNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGTGGGACTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSGGTSGTDTQYF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	3	3	0	18	30	-1	33	45						01,02								CASSGGTSGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTTATGAGGGGGCTCCTGGCTACACCTTCGGTTCG	CASSLGYEGAPGYTF	In	VDJ	1	46	3.5733983795415173E-4	4.743001495076558E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	7	8	3	18	32	47	40	50														CASSLGYEGAPGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGGAGATTTGACGAGCAGTACTTCGGGCCG	CASSLVGRFDEQYF	In	VDJ	1	50	3.884128673414693E-4	5.155436407691911E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	2	5	2	5	18	34	41	36	46														CASSLVGRFDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGACAGGCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSPGQAPNTEAFF	In	VDJ	1	51	3.9618112468829865E-4	5.258545135845749E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	3	4	18	30	40	33	44														CASSPGQAPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGACAGGGGGCGCCGATTAACTATGGCTACACCTTCGGTTCG	CASSPRQGAPINYGYTF	In	VDJ	1	51	3.9618112468829865E-4	5.258545135845749E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	0	1	4	6	18	30	44	34	50														CASSPRQGAPINYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAAGTAACTAGCGGGCGAAACATTCAGTACTTCGGCGCC	CASSLKVTSGRNIQYF	In	VDJ	1	51	3.9618112468829865E-4	5.258545135845749E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	2	3	4	6	6	2	18	33	48	39	50						01,02								CASSLKVTSGRNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCCGGGGACAGGGATTGGGTTCTAATGAAAAACTGTTTTTTGGCAGT	CASSARGQGLGSNEKLFF	In	VDJ	1	53	4.1171763938195746E-4	5.464762592153426E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	3	5	8	18	30	44	35	52														CASSARGQGLGSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGCCCATAAAGAGGAGAGCTACACCTTCGGTTCG	CASSPAHKEESYTF	In	VDJ	1	54	4.194858967287868E-4	5.567871320307264E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	2	9	14	1	18	30	48	44	49														CASSPAHKEESYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCTACAGGACAGTCCTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	54	4.194858967287868E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	0	6	3	18	30	42	36	45														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTGCTTCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSLGASANTEAFF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	9	1	0	9	18	-1	35	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGASANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTCCAGCGGGATGGGATTACAATGAGCAGTTCTTCGGGCCA	CASSLVPAGWDYNEQFF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	3	4	4	6	18	34	45	38	51														CASSLVPAGWDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCTGGCGCGGTCACCTATGGCTACACCTTCGGTTCG	CASSPGAVTYGYTF	In	VDJ	1	57	4.4279066876927497E-4	5.877197504768779E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	7	5	4	7	4	18	29	40	36	44						01,02								CASSPGAVTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACAATAGCGGGAGGGACGAGCAGTACTTCGGGCCG	CASSYNSGRDEQYF	In	VDJ	1	59	4.583271834629338E-4	6.083414961076455E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	5	0	5	4	0	18	31	-1	35	46														CASSYNSGRDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAACTTTAACAAGCAACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	60	4.660954408097631E-4		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	9	11	18	30	42	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCAAGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLQDRNTEAFF	In	VDJ	1	61	4.7386369815659253E-4	6.289632417384131E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	1	6	0	18	30	-1	36	41														CASSLQDRNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTCGGGACTAGCGGGACAGCCTACGAGCAGTACTTCGGGCCG	CASSQVGTSGTAYEQYF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	3	2	6	3	18	30	49	36	52														CASSQVGTSGTAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTCGGGACAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGTGSYEQYF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	0	4	0	18	29	-1	33	41														CASSLGTGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGCTGGTAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSMLVGGTEAFF	In	VDJ	1	68	5.282414995843982E-4	7.011393514460999E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	4	8	0	18	30	-1	38	44														CASSMLVGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLVGGNTEAFF	In	VDJ	1	68	5.282414995843982E-4	7.011393514460999E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	1	2	0	18	34	-1	36	41														CASSLVGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGAGGGAAACTATGGCTACACCTTCGGTTCG	CASSLGEGNYGYTF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	2	2	1	18	32	41	34	42														CASSLGEGNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTCGCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVASSYNEQFF	In	VDJ	1	71	5.515462716248864E-4	7.320719698922514E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	8	0	4	0	18	30	-1	34	38						01,02								CASSVASSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGACAAAACTGAGAAAAACTGTTTTTTGGCAGT	CASSSGQN*EKLFF	Stop	VDJ	1	72	5.593145289717158E-4		42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	6	8	2	7	18	31	38	33	45														CASSSGQN*EKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGGGGAGAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSPGGRGDNEQFF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	5	2	7	18	30	39	32	46														CASSPGGRGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACAGGGCTTCAAGAGACCCAGTACTTCGGGCCA	CASSLTGLQETQYF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	2	0	3	18	-1	39	32	42														CASSLTGLQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGACAGGGTGGCATCGAGCAGTACTTCGGGCCG	CASSLRQGGIEQYF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	3	6	2	6	18	32	41	34	47														CASSLRQGGIEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTCCCGGTCCCTACGAGCAGTACTTCGGGCCG	CASSLVPGPYEQYF	In	VDJ	1	80	6.214605877463508E-4	8.248698252307058E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	5	2	4	2	18	34	41	38	43						01,02								CASSLVPGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCCCAACTAGCGGGCCACTACGAGCAGTACTTCGGGCCG	CASRSQLAGHYEQYF	In	VDJ	1	81	6.292288450931802E-4	8.351806980460896E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	4	3	6	3	18	29	44	35	47						01,02								CASRSQLAGHYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGGGGAGGCAAGAGACCCAGTACTTCGGGCCA	CASSLWGRQETQYF	In	VDJ	1	81	6.292288450931802E-4	8.351806980460896E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	1	2	3	0	18	33	-1	36	42														CASSLWGRQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCAAATCCGACCTACAATGAGCAGTTCTTCGGGCCA	CASSLSNPTYNEQFF	In	VDJ	1	82	6.369971024400096E-4	8.454915708614734E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	2	8	2	8	0	18	33	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSNPTYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGGACTAGCGGGAGGGAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	82	6.369971024400096E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	0	7	1	3	18	27	44	28	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAAGCTAGAGCTGGCGTCGAGACCCAGTACTTCGGGCCA	CASKARAGVETQYF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	4	8	5	3	10	18	28	35	31	45						01,02								CASKARAGVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCGGGACAGGGGTCGTTTGGGTAATGAAAAACTGTTTTTTGGCAGT	CASNRDRGRLGNEKLFF	In	VDJ	1	83	6.44765359786839E-4	8.558024436768572E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	2	4	3	9	18	28	41	31	50														CASNRDRGRLGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAGCGCCAGTTCGTACGAGCAGTACTTCGGGCCG	CASSPSASSYEQYF	In	VDJ	1	85	6.603018744804977E-4	8.764241893076249E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	6	4	3	8	18	30	37	33	45						01,02								CASSPSASSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCGGCGGGATAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPRRDSSYEQYF	In	VDJ	1	85	6.603018744804977E-4	8.764241893076249E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	0	5	3	18	30	41	35	44														CASSPRRDSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGACAGCGGCTTCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	86	6.680701318273271E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	8	3	7	18	30	40	33	47														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTTGACAGTAAACACTGAAGCTTTCTTTGGACAA	CASSLDLTVNTEAFF	In	VDJ	1	86	6.680701318273271E-4	8.867350621230087E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	5	2	3	2	18	35	43	38	45														CASSLDLTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGCGACCGGGACAGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSERPGQGRTEAFF	In	VDJ	1	91	7.069114185614741E-4	9.382894261999278E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	5	8	3	18	30	48	38	51														CASSERPGQGRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGCGGAAGAAGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	97	7.535209626424504E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	5	4	2	7	18	33	39	35	46						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTAGGGACAGGGAGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLLGTGRGNEKLFF	In	VDJ	1	106	8.234352787639149E-4	0.0010929525184306852	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	3	4	3	5	18	33	45	36	50														CASSLLGTGRGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAATTGGACAGGGGCGTCAGCCCCAGCATTTTGGTGAT	CASSPIGQGRQPQHF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	2	6	6	2	18	30	45	36	47														CASSPIGQGRQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAAAGGAGGGACAGGATGAACACAGATACGCAGTATTTTGGCCCA	CASKRRDRMNTDTQYF	In	VDJ	1	113	8.778130801917206E-4	0.001165128628138372	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	4	2	6	5	18	28	42	34	47														CASKRRDRMNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGCGCTAGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSLGALAGGNEQFF	In	VDJ	1	113	8.778130801917206E-4	0.001165128628138372	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	1	6	5	0	18	34	-1	39	50														CASSLGALAGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCAAAGGGAGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPKGGGNQPQHF	In	VDJ	1	115	8.933495948853793E-4	0.0011857503737691395	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	1	2	6	2	18	29	41	35	43														CASSPKGGGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAATGAGCTCGGCGACACCGTCCTACGAGCAGTACTTCGGGCCG	CASSPMSSATPSYEQYF	In	VDJ	1	116	9.011178522322087E-4	0.0011960612465845234	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	6	1	14	3	18	30	48	44	51														CASSPMSSATPSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATGGACTAGCGGGGGGCTCTTATGAGAGCAGTTCTTCGGGCCA		Out	VDJ	1	116	9.011178522322087E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	1	10	2	9	18	31	47	33	56														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCGATTAGCGGGAGGTATCGATACGCAGTATTTTGGCCCA	CASSFRLAGGIDTQYF	In	VDJ	1	116	9.011178522322087E-4	0.0011960612465845234	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	1	6	5	4	18	32	47	37	51														CASSFRLAGGIDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAAACTTTTAAGACAGGTTGGACTACGAGCAGTACTTCGGGCCG	CASSLVNF*DRLDYEQYF	Stop	VDJ	1	120	9.321908816195262E-4		54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	4	3	11	5	18	34	51	45	56														CASSLVNF*DRLDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCTCAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSLAQLNTEAFF	In	VDJ	1	120	9.321908816195262E-4	0.0012373047378460586	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	4	5	0	4	1	18	32	39	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAQLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCATTACTAGCGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSITSGSTDTQYF	In	VDJ	1	121	9.399591389663557E-4	0.0012476156106614425	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	5	0	3	1	18	30	41	33	42						01,02								CASSITSGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTGGGCGGGAGTGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSLLGGSGSGELFF	In	VDJ	1	141	0.0010953242859029434	0.001453833066969119	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	7	2	6	5	5	18	32	44	37	49														CASSLLGGSGSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCCGGGACTAGCGGGCAATGAGCAGTTCTTCGGGCCA	CASSWPGLAGNEQFF	In	VDJ	1	155	0.0012040798887585549	0.0015981852863844925	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	4	6	4	0	18	31	-1	35	47						01,02								CASSWPGLAGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCCTAGACCTAAAAGCCTAGGTGAGCAGTTCTTCGGGCCA	CASSFPRPKSLGEQFF	In	VDJ	1	162	0.0012584576901863605	0.0016703613960921792	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	9	2	15	18	32	38	34	53						01,02								CASSFPRPKSLGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCTTAGCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	165	0.0012817624622268487		43	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	5	7	4	3	0	18	35	-1	38	42						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGAACAATGACAGGGGGGTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	175	0.0013594450356951425		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	1	4	9	2	18	30	48	39	50														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGACAAGTTAACACTGAAGCTTTCTTTGGACAA	CASSLAGQVNTEAFF	In	VDJ	1	198	0.0015381149546722184	0.0020415528174459966	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	6	2	4	4	18	32	41	36	45														CASSLAGQVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCTACCGGGGACAGATATCAGCCCCAGCATTTTGGTGAT	CASSSTGDRYQPQHF	In	VDJ	2	355	0.002757731358124432	0.0036603598494612567	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	5	8	2	18	29	44	37	46														CASSSTGDRYQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGTCCCTCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	423	0.00328597285770883		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	2	6	18	30	39	32	45														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAACCCGAGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	840	0.006525336171336684		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	2	0	7	0	18	35	-1	42	46														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCCGTGGAGGCCACAGATACGCAGTATTTTGGCCCA	CASSLSVEATDTQYF	In	VDJ	42	6790	0.05274646738497153	0.07001082641645616	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	1	2	6	1	18	32	43	38	44														CASSLSVEATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
TATTTTTGTGCTAGTGGTTTGGTAACCTCGGGACAGAATCCGACCATGCCTGGAAACACCATATATTTTGGAGAG	CASGLVTSGQNPTMPGNTIYF	In	VDJ	1	91	7.069114185614741E-4	9.382894261999278E-4	63	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	5	2	6	13	6	23	36	29	49														CASGLVTSGQNPTMPGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTATGGCAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASGMAGQSRANVLTF	In	VDJ	1	141	0.0010953242859029434	0.001453833066969119	48	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	1	6	5	2	5	26	42	49	44	54														CASGMAGQSRANVLTF+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCCTAGTTGGGTTATAGAATTTATTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	141	0.0010953242859029434		61	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	4	8	2	3	19	16	31	38	34	57						01,02								X+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCACCACCTTACTAGCAGAAATAGATACGCAGTATTTTGGCCCA	CATTLLAEIDTQYF	In	VDJ	1	149	0.0011574703446775784	0.0015363200494921895	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	12	3	7	5	9	6	26	31	46	40	52						01,02								CATTLLAEIDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCTCGAGTGGAAACACCATATATTTTGGAGAG	CASGPSSGNTIYF	In	VDJ	1	157	0.0012196164034522137	0.0016188070320152601	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	2	3	5	0	26	38	-1	43	46														CASGPSSGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCTACTAGCGAGTGCGACAGATACGCAGTATTTTGGCCCA	CASTLLASATDTQYF	In	VDJ	4	716	0.0055620722603298405	0.0073825849358148165	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	12	3	6	3	9	6	26	31	47	40	53						01,02								CASTLLASATDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAACTAGCGGACTAGCGGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	58	4.5055892611610437E-4		52	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	1	3	2	6	0	20	35	-1	41	53														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGGCAGCATCGGGGAGGCACGAGCAGTACTTCGGGCCG	CASSQAASGRHEQYF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	5	13	1	20	31	50	44	51														CASSQAASGRHEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACGGACAGGGCAATGGGTTAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	73	5.670827863185451E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	0	1	11	20	34	43	35	54														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGTATGTGGCTAGCGGGAGGTATCAATGAGCAGTTCTTCGGGCCA	CASSQGMWLAGGINEQFF	In	VDJ	1	76	5.903875583590333E-4	7.836263339691705E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	1	6	9	3	20	35	55	44	58														CASSQGMWLAGGINEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSQQGAGNTIYF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	1	2	0	0	20	-1	-1	35	42														CASSQQGAGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTAGGTGGGTTAGTGAAAAACTGTTTTTTGGCAGT	CASSRWVSEKLFF	In	VDJ	1	86	6.680701318273271E-4	8.867350621230087E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-04	01	5	0	9	7	4	4	20	32	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWVSEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCACTACCGGGACTACCTACGTCTCGGAGCAGTACTTCGGGCCG	CASSTTGTTYVSEQYF	In	VDJ	1	89	6.913749038678154E-4	9.176676805691602E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	9	7	7	11	20	31	45	38	56						01,02								CASSTTGTTYVSEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCACTGAGCCCGGCACTGAGCAGTTCTTCGGGCCA	CASSTEPGTEQFF	In	VDJ	1	173	0.0013439085210014837	0.0017837809970614013	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	6	9	0	9	10	2	20	31	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTEPGTEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCATTTTATGGGACGGTAGAAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	175	0.0013594450356951425		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-04	01	7	0	7	8	6	7	20	30	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01		TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATGTGGCCCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSHVAPSGANVLTF	In	VDJ	1	204	0.0015847244987531946	0.0021034180543382996	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	9	0	0	3	3	20	34	40	37	43														CASSHVAPSGANVLTF+TCRBV23-01+TCRBJ02-06	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGGACCCCAAACCGGAGTCCGCGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	227	0.0017633944177302707		50	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	7	3	4	18	0	20	28	-1	46	52														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCGAGGGGACAATCAGCCCCAGCATTTTGGTGAT	CASSQDRGDNQPQHF	In	VDJ	2	314	0.0024392328069044273	0.0032376140640305202	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	2	5	2	3	5	1	20	35	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRGDNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTCGTGGTAGGACAGGGTCAATTTGGGGAAACACCATATATTTTGGAGAG		Out	VDJ	3	481	0.0037365317838249346		61	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	3	4	9	9	20	37	54	46	63														X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTAAAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	9	1479	0.011489252615960661		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	0	5	4	1	4	0	20	37	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATGACTAGCGGGCTTTCTAGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	3.6510809530098114E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	4	6	2	10	23	34	46	36	56						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSYPGTQETQYF	In	VDJ	1	47	3.6510809530098114E-4	4.8461102232303966E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	0	7	1	3	0	23	38	-1	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAATCAAGCCTACGAGCAGTACTTCGGGCCG	CASSYNQAYEQYF	In	VDJ	1	51	3.9618112468829865E-4	5.258545135845749E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	4	6	2	3	2	23	38	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNQAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGGGGAGGGCTCTTATGAACACTGAAGCTTTCTTTGGACAA	CASRTGRALMNTEAFF	In	VDJ	1	52	4.0394938203512805E-4	5.361653863999588E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	0	4	6	23	34	45	38	51														CASRTGRALMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTGAGTCAGGGTAAGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	53	4.1171763938195746E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	4	3	5	6	5	23	30	41	36	46														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTGCAGAAATAAGCGAGCAGTACTTCGGGCCG	CASSFAEISEQYF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	5	6	3	7	23	36	42	39	49														CASSFAEISEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCACAAAAACGCCGGGGGTTCTACATGGCTACACCTTCGGTTCG	CASATKTPGVLHGYTF	In	VDJ	1	55	4.272541540756162E-4	5.670980048461102E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	8	2	6	13	6	23	32	51	45	57														CASATKTPGVLHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACCACTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSTTYTGELFF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	2	7	3	0	5	23	-1	43	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSTTYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYFSSYNEQFF	In	VDJ	1	56	4.350224114224456E-4	5.77408877661494E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	8	0	1	0	23	39	-1	40	43						01,02								CASSYFSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAATGGGGCGGAGGGAACCTACGAGCAGTACTTCGGGCCG	CASSYNGAEGTYEQYF	In	VDJ	1	57	4.4279066876927497E-4	5.877197504768779E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	2	9	2	23	37	52	46	54														CASSYNGAEGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAGGACTAGCGGACCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	63	4.894002128502513E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	5	0	4	4	23	40	54	44	58						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGGACTAGCGGGACTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	63	4.894002128502513E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	3	4	2	2	23	36	50	38	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTACAGGACCGAGCCTACGAGCAGTACTTCGGGCCG	CASSVQDRAYEQYF	In	VDJ	1	66	5.127049848907395E-4	6.805176058153323E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	2	2	6	23	35	42	37	48														CASSVQDRAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGCTAGCGGGAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSYPASGRGNEQFF	In	VDJ	1	70	5.43778014278057E-4	7.217610970768675E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	0	6	4	1	23	38	54	42	55														CASSYPASGRGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCATTCGGCGGGATCTCCTACGAGCAGTACTTCGGGCCG	CASSYSFGGISYEQYF	In	VDJ	1	72	5.593145289717158E-4	7.423828427076352E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	0	5	1	23	40	51	45	52														CASSYSFGGISYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACGCGATCGGGGACAGGGGAAGTACTTCGGGCCG		Out	VDJ	1	75	5.826193010122039E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	2	11	11	1	23	30	51	41	52														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATGGAGTTAGGGGAGCTGTTTTTTGGAGAA	CASSMELGELFF	In	VDJ	1	81	6.292288450931802E-4	8.351806980460896E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	2	8	2	3	23	35	41	37	44														CASSMELGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATTCGGGACAGGGCACCTGGCTACACCTTCGGTTCG	CASSIRDRAPGYTF	In	VDJ	1	81	6.292288450931802E-4	8.351806980460896E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	7	4	4	23	35	48	39	52														CASSIRDRAPGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGGCAGGGCAGGGAGACCCAGTACTTCGGGCCA	CASSDRQGRETQYF	In	VDJ	1	82	6.369971024400096E-4	8.454915708614734E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	5	6	4	23	35	46	41	50														CASSDRQGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACCGGGACAAAGTCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	84	6.525336171336684E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	0	4	7	23	34	44	38	51														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGACGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSYWDGSYNEQFF	In	VDJ	1	86	6.680701318273271E-4	8.867350621230087E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	1	0	7	1	0	3	23	-1	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYWDGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAACAGGGGGCGCGCACCGGGGAGCTGTTTTTTGGAGAA	CASREQGARTGELFF	In	VDJ	1	91	7.069114185614741E-4	9.382894261999278E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	0	4	3	3	23	34	46	37	49														CASREQGARTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGCAGCGGAATACACCGGGGAGCTGTTTTTTGGAGAA	CASSWAAEYTGELFF	In	VDJ	1	93	7.224479332551329E-4	9.589111718306955E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	6	5	3	4	3	23	36	45	40	48						01,02								CASSWAAEYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTAGCGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSYSLAGTYNEQFF	In	VDJ	1	95	7.379844479487917E-4	9.795329174614631E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	3	2	2	1	23	40	50	42	51														CASSYSLAGTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTTGGAGGGGGAGGGGTAACCTACGAGCAGTACTTCGGGCCG	CASRFGGGGVTYEQYF	In	VDJ	1	99	7.690574773361092E-4	0.0010207764087229983	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	2	9	4	23	34	50	43	54														CASRFGGGGVTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGTGAACAGGAACACTGAAGCTTTCTTTGGACAA	CASIVNRNTEAFF	In	VDJ	1	101	7.84593992029768E-4	0.0010413981543537661	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	5	1	6	0	23	33	-1	39	43														CASIVNRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTACTAGCGGGAGTATCACCGGGGAGCTGTTTTTTGGAGAA	CASSGTSGSITGELFF	In	VDJ	1	106	8.234352787639149E-4	0.0010929525184306852	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	3	2	4	3	3	23	35	49	38	52														CASSGTSGSITGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCGGCAGGGGGGCAGCACTATGGCTACACCTTCGGTTCG	CASSAGGQHYGYTF	In	VDJ	1	107	8.312035361107443E-4	0.001103263391246069	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	4	1	3	4	5	23	32	43	36	48														CASSAGGQHYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGGATAGGGACAATGAGCAGTTCTTCGGGCCA	CAISADRDNEQFF	In	VDJ	1	108	8.389717934575736E-4	0.0011135742640614528	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	5	3	5	6	0	23	35	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISADRDNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCGGAAGCGGCGGGCTTAATCTGAACACTGAAGCTTTCTTTGGACAA	CVSGSGGLNLNTEAFF	In	VDJ	1	120	9.321908816195262E-4	0.0012373047378460586	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	6	5	0	3	11	23	32	40	35	51						01,02								CVSGSGGLNLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACACCTCATGGGGTAGCGTAGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	137	0.0010642512565156258		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	5	6	3	13	3	23	33	51	46	54						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGCGGGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	143	0.0011108608005966022		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	2	0	0	1	23	-1	47	40	48														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCACTCCCCGGGACAGGGAGCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	179	0.0013905180650824601		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	6	8	3	23	36	53	44	56														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCGGACTAGCGGGGTCCCTCCGGGGAGCTGTTTTTTGGAGAA	CASRPD*RGPSGELFF	Stop	VDJ	1	181	0.0014060545797761187		48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	6	3	5	23	34	49	37	54														CASRPD*RGPSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCGGGACAGAAATGGCTACACCTTCGGTTCG	CASSPRDRNGYTF	In	VDJ	1	184	0.001429359351816607	0.0018972005980306232	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	5	2	23	34	46	39	48														CASSPRDRNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATAAATTGGTGGGTGCTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSINWWVLQSRANVLTF	In	VDJ	1	196	0.0015225784399785596	0.0020209310718152292	57	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	0	9	5	10	12	23	35	48	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSINWWVLQSRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGTGACGGTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASST*R*QSRANVLTF	Stop	VDJ	1	213	0.0016546388148746592		51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	10	5	23	35	49	45	54														CASST*R*QSRANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGCGGGACCATAAAGACGACCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	221	0.0017167848736492942		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	7	3	3	2	13	23	35	43	37	56														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCAGGGGGACACCGTATATGGCTACACCTTCGGTTCG	CATQGDTVYGYTF	In	VDJ	1	225	0.0017478579030366119	0.00231994638346136	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	1	5	2	8	23	30	39	32	47														CATQGDTVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCATGGGGCAGTCCAACGCCACGGTATGGCTACACCTTCGGTTCG	CASSYSPWGSPTPRYGYTF	In	VDJ	2	248	0.0019265278220136877	0.002557096458215188	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	5	5	15	23	40	50	45	65														CASSYSPWGSPTPRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCATTTACCCGTGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	337	0.002617902725881503		40	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	3	7	5	7	5	23	35	44	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLGYQETQYF	In	VDJ	6	946	0.007348771450100599	0.009754085683353095	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	4	0	3	1	23	34	41	37	42						01,02								CASSLGYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGTGTAATCGGACCGGGACTAGCGGGAACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	952	0.007395380994181576		62	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	2	15	2	19	34	62	49	64														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGGGACAGGGGGTAAACACTGAAGCTTTCTTTGGACAA	CASSPGGQGVNTEAFF	In	VDJ	1	58	4.5055892611610437E-4	5.980306232922617E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	2	3	2	24	38	52	41	54													Vb 18	CASSPGGQGVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPGRNTEAFF	In	VDJ	1	62	4.8163195550342193E-4	6.39274114553797E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	2	1	0	0	24	-1	-1	39	44													Vb 18	CASSPGRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASSPGQGNTEAFF	In	VDJ	1	73	5.670827863185451E-4	7.52693715523019E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	2	1	1	24	38	47	39	48													Vb 18	CASSPGQGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCACGGGGACTGTTGAGCAGTTCTTCGGGCCA	CASSPTGTVEQFF	In	VDJ	1	77	5.981558157058627E-4	7.939372067845543E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	9	4	2	24	38	48	42	50						01,02							Vb 18	CASSPTGTVEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGTCTCTTCTCCTCAGTGGTTCAGGGGGCGGAGAGACCCAGTACTTCGGGCCA	CASSSSLLLSGSGGGETQYF	In	VDJ	1	79	6.136923303995214E-4	8.145589524153219E-4	60	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	4	22	2	21	33	63	55	65													Vb 18	CASSSSLLLSGSGGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGTCCTCCGACAGGGGGCTATTATATGGCTACACCTTCGGTTCG	CASSPQSSDRGLLYGYTF	In	VDJ	1	95	7.379844479487917E-4	9.795329174614631E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	0	5	10	5	24	38	58	48	63													Vb 18	CASSPQSSDRGLLYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCGGCGGGGCAAAACCAAATGAGCAGTTCTTCGGGCCA	CASSPPGGAKPNEQFF	In	VDJ	1	96	7.457527052956211E-4	9.89843790276847E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	3	7	2	8	24	41	49	43	57													Vb 18	CASSPPGGAKPNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAAGGACAGGGGGGCGACACTGAAGCTTTCTTTGGACAA	CASSQGQGGDTEAFF	In	VDJ	1	111	8.622765654980618E-4	0.0011445068825076043	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	1	3	2	3	24	37	49	39	52													Vb 18	CASSQGQGGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGGACAGGGGGGCGGGTGAAGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	121	9.399591389663557E-4		50	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	1	5	1	11	24	36	48	37	59													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAAAGGGACAGGGGGCGCAGGGCTACACCTTCGGTTCG	CASSPPKGQGAQGYTF	In	VDJ	1	128	9.943369403941614E-4	0.0013197917203691292	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	0	8	3	4	24	41	56	44	60													Vb 18	CASSPPKGQGAQGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGCGGCAGATACGCAGTATTTTGGCCCA	CASSRAADTQYF	In	VDJ	1	128	9.943369403941614E-4	0.0013197917203691292	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	4	8	0	4	0	2	24	-1	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRAADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTTGGACAGGGACCTGGAAACACCATATATTTTGGAGAG	CASSPLGQGPGNTIYF	In	VDJ	1	135	0.001048714741821967	0.001391967830076816	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	2	4	2	24	38	50	42	52													Vb 18	CASSPLGQGPGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAGACAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSKTGLNTEAFF	In	VDJ	1	140	0.001087556028556114	0.001443522194153735	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	0	2	1	24	36	45	38	46													Vb 18	CASSKTGLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGAAAGAACCGGGGAGCTGTTTTTTGGAGAA	CASSPPERTGELFF	In	VDJ	1	140	0.001087556028556114	0.001443522194153735	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	0	2	8	5	1	4	24	41	44	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPERTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAACAGGAAAATCAGCCCCAGCATTTTGGTGAT	CASSQQENQPQHF	In	VDJ	1	217	0.0016857118442619766	0.0022374594009382893	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	4	1	2	24	37	43	38	45													Vb 18	CASSQQENQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGACAGAGTTTACGTGGGACTAGCGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	227	0.0017633944177302707		61	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	4	18	0	20	34	-1	52	63						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTTCGGGACCCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLRDPYSNQPQHF	In	VDJ	2	250	0.0019420643367073465	0.0025777182038459554	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	6	0	7	0	5	5	24	35	45	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLRDPYSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGACAGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQGQGGETQYF	In	VDJ	2	282	0.002190648571805887	0.002907666133938238	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	1	4	1	1	24	37	49	38	50													Vb 18	CASSQGQGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGACAGGTGCCTACACAGATACGCAGTATTTTGGCCCA	CASSPGTGAYTDTQYF	In	VDJ	2	282	0.002190648571805887	0.002907666133938238	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	4	2	1	6	24	38	47	39	53													Vb 18	CASSPGTGAYTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGAAGACTTTAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPTKTLTSTDTQYF	In	VDJ	3	494	0.0038375191293337167	0.005093571170799608	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	10	0	6	6	24	38	48	44	54						01,02							Vb 18	CASSPTKTLTSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTATNEKLFF	In	VDJ	4	621	0.004824087812381048	0.006403052018353354	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	2	10	0	0	1	24	-1	42	38	43						01,02							Vb 18	CASSPTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
GAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGACAGGGTTTACGTGGGACTAGCGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDDJ	5	850	0.006603018744804978		61	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	5	4	7	0	20	45	-1	52	63						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	6986B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				978	736	197	43	0	638	481	139	18	0	128729	96985	26038	5706	0	0.101920269	8.00179482	0.0957567692	8.42520714				125065	0.0061953618568810105	0.070010826	0.0527464673	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:38	Age (Range):45-65 Years (Late Adulthood),Age:50 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 832,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 551,type of chemo:carbo/taxol x 1, carbo/taxotere x 4	0.7525562167068238	MSKCC- Snyder- P01-02		775.0	
